Niklas Hammar

Publikationer
Forskningsbidrag
Populärvetenskap och samverkan

Artiklar

Journal article: EUROPEAN JOURNAL OF PUBLIC HEALTH. 2024;34(6):1066-1072
Sociodemographic differences in the response to changes in COVID-19 testing guidelines
Sharma S; Li H; Love J; Nwaru C; Gisslen M; Byfors S; Hammar N; Nilsson A; Bjork J; Nyberg F; Bonander C
Article: JAMA PSYCHIATRY. 2024;81(11):1118
Inflammatory Biomarkers and Risk of Psychiatric Disorders
Zeng Y; Chourpiliadis C; Hammar N; Seitz C; Valdimarsdottir UA; Fang F; Song H; Wei D
Article: BMC MEDICINE. 2024;22(1):460
Surgical removal of tonsils and risk of COVID-19: a nested case-control study using data from UK Biobank and AMORIS Cohort
Yang Y; Hu K; Modig K; Feychting M; Janszky I; Hammar N; Fang F; Zhang Z; Wei D
Journal article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;:S1542-3565(24)00679-7
Biomarkers for Prediction of Alcohol-Related Liver Cirrhosis: A General Population-Based Swedish Study of 537,250 Individuals.
Jakobsson G; Talbäck M; Hammar N; Shang Y; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2024;80:s40
OS-057-YI CORE: a new risk score measuring GGT, AST, and ALT outperforms FIB-4 when predicting the risk of cirrhosis in a primary care setting
Strandberg R; Talbäck M; Hammar N; Hagström H
Article: EPIDEMIOLOGY. 2024;35(3):340-348
A Capture-Recapture-based Ascertainment Probability Weighting Method for Effect Estimation With Under-ascertained Outcomes
Bonander C; Nilsson A; Li H; Sharma S; Nwaru C; Gisslen M; Lindh M; Hammar N; Bjork J; Nyberg F
Article: JAMA NETWORK OPEN. 2024;7(4):e244525
Metabolic Profile and Long-Term Risk of Depression, Anxiety, and Stress-Related Disorders
Chourpiliadis C; Zeng Y; Lovik A; Wei D; Valdimarsdottir U; Song H; Hammar N; Fang F
Article: GEROSCIENCE. 2024;46(2):1693-1702
Blood biomarker profiles and exceptional longevity: comparison of centenarians and non-centenarians in a 35-year follow-up of the Swedish AMORIS cohort
Murata S; Ebeling M; Meyer AC; Schmidt-Mende K; Hammar N; Modig K
Journal article: ESMO OPEN. 2023;8(1):101655
9O Pancreatic cancer risk in individuals with newly diagnosed diabetes: Insights from the AMORIS cohort in Sweden
Zhang Z; Carlsson S; Hammar N; Nunez MDPA; Brennan P; Oldfield L; Golbabaee M; Sarker D; Kordasti S; Kunzmann A; van Hemelrijck M; Santaolalla A
Article: PRIMARY CARE DIABETES. 2023;17(5):411-419
Considerations when planning and conducting large global observational studies: Experience from the DISCOVER study of patients with type 2 diabetes
Aarskog P; Cid-Ruzafa J; Chen H; Fenici P; Gutierrez LR; Hammar N; Medina J; Pascual E; Saraiva GL; Surmont F; Sweet S; Ji L; Khunti K; Cooper A
Article: DIABETES, OBESITY AND METABOLISM. 2023;25(7):1890-1899
HbA1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER study
Bongaerts B; Kuss O; Bonnet F; Chen H; Cooper A; Fenici P; Gomes MB; Hammar N; Ji L; Khunti K; Medina J; Nicolucci A; Shestakova MV; Watada H; Rathmann W
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s121
A new risk model outperforms FIB-4 when predicting incident cirrhosis in the general population: a cohort study of 504,000 persons
Strandberg R; Talback M; Hammar N; Hagstrom H
Article: CANCER LETTERS. 2023;557:216091
Blood metabolic biomarkers and the risk of head and neck cancer: An epidemiological study in the Swedish AMORIS Cohort
Huang Y; Xiao X; Sadeghi F; Feychting M; Hammar N; Fang F; Zhang Z; Liu Q
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2023;12(3):e027089
Elevated Uric Acid Is Associated With New-Onset Atrial Fibrillation: Results From the Swedish AMORIS Cohort
Ding M; Viet NN; Gigante B; Lind V; Hammar N; Modig K
Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2023;57(4):418-425
Improved prediction of 10-year risk of severe liver disease in the general population using commonly available biomarkers
Hagstrom H; Yan J; Talback M; Andreasson A; Walldius G; Bottai M; Hammar N
Article: CANCERS. 2023;15(2):520
Carbohydrate, Lipid, and Apolipoprotein Biomarkers in Blood and Risk of Thyroid Cancer: Findings from the AMORIS Cohort
Xiao X; Huang Y; Sadeghi F; Feychting M; Hammar N; Fang F; Zhang Z; Liu Q
Article: VACCINE. 2022;40(46):6640-6648
An intersectional analysis of sociodemographic disparities in Covid-19 vaccination: A nationwide register-based study in Sweden
Spetz M; Lundberg L; Nwaru C; Li H; Santosa A; Ng N; Leach S; Gisslen M; Hammar N; Nyberg F; Rosvall M
Article: PLOS MEDICINE. 2022;19(8):e1004044
Lipid levels in midlife and risk of atrial fibrillation over 3 decades-Experience from the Swedish AMORIS cohort: A cohort study
Ding M; Wennberg A; Gigante B; Walldius G; Hammar N; Modig K
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s119-s120
THU002 Biomarkers for prediction of alcohol-related liver cirrhosis in the Swedish general population
Jakobsson G; Talbäck M; Walldius G; Hammar N; Shang Y; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s24
OS016 Prediction of ten-year risk of severe liver disease in the general population using commonly available biomarkers
Hagström H; Yan J; Talbäck M; Andreasson A; Walldius G; Bottai M; Hammar N
Article: THE LANCET REGIONAL HEALTH. EUROPE. 2022;15:100331
The social patterning of Covid-19 vaccine uptake in older adults: A register-based cross-sectional study in Sweden
Spetz M; Lundberg L; Nwaru C; Li H; Santosa A; Leach S; Gisslen M; Hammar N; Rosvall M; Nyberg F
Article: JOURNAL OF ALZHEIMER'S DISEASE. 2022;86(1):245-257
Glucose-Lowering Medications and Post-Dementia Survival in Patients with Diabetes and Dementia
Secnik J; Xu H; Schwertner E; Hammar N; Alvarsson M; Winblad B; Eriksdotter M; Garcia-Ptacek S; Religa D
Article: DIABETES RESEARCH AND CLINICAL PRACTICE. 2022;185:109218
Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER study
Nicolucci A; Chen H; Cooper A; Fenici P; Gomes MB; Hammar N; Ji L; Khunti K; Kosiborod M; Medin J; Shestakova MV; Shimomura I; Tang F; Vora J; Watada H; Arnold SV
Article: ENDOCRINOLOGY, DIABETES & METABOLISM. 2022;5(2):e00321
Impact of micro- and macrovascular complications of type 2 diabetes on quality of life: Insights from the DISCOVER prospective cohort study
Arnold SV; Khunti K; Tang F; Chen H; Nicolucci A; Gomes MB; Ji L; Shestakova MV; Watada H; Cooper A; Fenici P; Hammar N; Medina J; Kosiborod M
Article: DIABETES CARE. 2022;45(2):330-338
Alterations in Biomarkers Related to Glycemia, Lipid Metabolism, and Inflammation up to 20 Years Before Diagnosis of Type 1 Diabetes in Adults: Findings From the AMORIS Cohort
Herzog K; Andersson T; Grill V; Hammar N; Malmstrom H; Talback M; Walldius G; Carlsson S
Article: AMERICAN HEART JOURNAL. 2022;243:232-239
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study
Arnold SV; Khunti K; Tang F; Chen H; Cid-Ruzafa J; Cooper A; Fenici P; Gomes MB; Hammar N; Ji L; Saraiva GL; Medina J; Nicolucci A; Ramirez L; Rathmann W; Shestakova MV; Shimomura I; Surmont F; Vora J; Watada H; Kosiborod M
Article: SCIENTIFIC REPORTS. 2021;11(1):24440
The association of apolipoproteins with later-life all-cause and cardiovascular mortality: a population-based study stratified by age
Ding M; Wennberg A; Ek S; Santoni G; Gigante B; Walldius G; Hammar N; Modig K
Article: ALZHEIMER'S RESEARCH AND THERAPY. 2021;13(1):197
The association of antidiabetic medications and Mini-Mental State Examination scores in patients with diabetes and dementia
Secnik J; Xu H; Schwertner E; Hammar N; Alvarsson M; Winblad B; Eriksdotter M; Garcia-Ptacek S; Religa D
Article: PLOS MEDICINE. 2021;18(12):e1003853
Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio-Experience from the Swedish AMORIS cohort: A cohort study
Walldius G; de Faire U; Alfredsson L; Leander K; Westerholm P; Malmstrom H; Ivert T; Hammar N
Article: CARDIOVASCULAR DIABETOLOGY. 2021;20(1):227
Impaired fasting glucose: a risk factor for atrial fibrillation and heart failure
Lind V; Hammar N; Lundman P; Friberg L; Talback M; Walldius G; Norhammar A
Article: CANCERS. 2021;13(21):5540
Serum Total Bilirubin and Risk of Cancer: A Swedish Cohort Study and Meta-Analysis
Monroy-Iglesias MJ; Moss C; Beckmann K; Hammar N; Walldius G; Bosco C; Van Hemelrijck M; Santaolalla A
Article: DIABETES RESEARCH AND CLINICAL PRACTICE. 2021;180:108974
Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER study
Nicolucci A; Chen H; Cid-Ruzafa J; Cooper A; Fenici P; Gomes MB; Hammar N; Khunti K; Kosiborod M; Leigh P; Medin J; Rathmann W; Shestakova MV; Shimomura I; Siddiqui A; Tang F; Watada H; Ji L
Article: BMC IMMUNOLOGY. 2021;22(1):61
Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study
Santaolalla A; Sollie S; Rislan A; Josephs DH; Hammar N; Walldius G; Garmo H; Karagiannis SN; Van Hemelrijck M
Article: THE JOURNALS OF GERONTOLOGY. SERIES A, BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. 2021;76(9):1643-1652
Blood-Based Biomarkers and Long-term Risk of Frailty-Experience From the Swedish AMORIS Cohort
Wennberg AM; Ding M; Ebeling M; Hammar N; Modig K
Article: DIABETES RESEARCH AND CLINICAL PRACTICE. 2021;178:108947
Early versus late intensification of glucose-lowering therapy in patients with type 2 diabetes: Results from the DISCOVER study
Ji L; Bonnet F; Chen H; Cooper A; Hammar N; Leigh P; Saraiva GL; Ramirez L; Medina J; Nicolucci A; Rathmann W; Shestakova MV; Surmont F; Tang F; Watada H
Article: DIABETES, OBESITY AND METABOLISM. 2021;23(8):1956-1960
Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study
Khunti K; Charbonnel B; Chen H; Cherney DZ; Cooper A; Fenici P; Gomes MB; Hammar N; Heerspink HJL; Ji L; Medina J; Nicolucci A; Ramirez L; Rathmann W; Shestakova MV; Shimomura I; Tang F; Watada H; Kosiborod M
Article: HEART LUNG AND CIRCULATION. 2021;30(7):1050-1057
Elevated Apolipoprotein B/A-1 Ratio is Associated With an Increased Risk of Aortic Stenosis: Experience From the AMORIS Cohort
Ivert T; Hammar N; Talback M; Malmstrom H; Leander K; Walldius G
Article: HEPATOLOGY COMMUNICATIONS. 2021;5(6):1021-1035
A Dynamic Aspartate-to-Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease
Aberg F; Danford CJ; Thiele M; Talback M; Rasmussen DN; Jiang ZG; Hammar N; Nasr P; Ekstedt M; But A; Puukka P; Krag A; Sundvall J; Erlund I; Salomaa V; Stal P; Kechagias S; Hultcrantz R; Lai M; Afdhal N; Jula A; Mannisto S; Lundqvist A; Perola M; Farkkila M; Hagstrom H
Article: ESC HEART FAILURE. 2021;8(2):1711-1716
Type 2 diabetes and heart failure: insights from the global DISCOVER study
Arnold SV; Khunti K; Bonnet F; Charbonnel B; Chen H; Cid-Ruzafa J; Cooper A; Fenici P; Gomes MB; Hammar N; Ji L; Luporini-Saraiva G; Medina J; Nicolucci A; Ramirez L; Shestakova MV; Shimomura I; Surmont F; Tang F; Vora J; Watada H; Kosiborod M
Article: CLINICAL EPIDEMIOLOGY. 2021;13:649-659
Swedish Covid-19 Investigation for Future Insights-A Population Epidemiology Approach Using Register Linkage (SCIFI-PEARL)
Nyberg F; Franzen S; Lindh M; Vanfleteren L; Hammar N; Wettermark B; Sundstrom J; Santosa A; Bjorck S; Gisslen M
Article: DIABETES, OBESITY AND METABOLISM. 2021;23(1):39-48
Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from theDISCOVERstudy
Patel KK; Gomes MB; Charbonnel B; Chen H; Cid-Ruzafa J; Fenici P; Hammar N; Ji L; Kennedy KF; Khunti K; Kosiborod M; Pocock S; Shestakova MV; Shimomura I; Surmont F; Watada H; Arnold SV
Journal article: ALZHEIMER'S AND DEMENTIA. 2020;16(S10)
Dementia diagnosis affects pharmacological management of diabetes mellitus: A matched analysis of ∼20,000 patients from the Swedish registries
Secnik J; Xu H; Schwertner E; Hammar N; Alvarsson M; Winblad B; Eriksdotter M; Garcia‐Ptacek S; Religa D
Article: JOURNAL OF HEPATOLOGY. 2020;73(5):1023-1029
Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease
Hagstrom H; Talback M; Andreasson A; Walldius G; Hammar N
Article: BRITISH JOURNAL OF SPORTS MEDICINE. 2020;54(21):1294-1299
A Swedish primary healthcare prevention programme focusing on promotion of physical activity and a healthy lifestyle reduced cardiovascular events and mortality: 22-year follow-up of 5761 study participants and a reference group
Journath G; Hammar N; Vikstrom M; Linnersjo A; Walldius G; Krakau I; Lindgren P; de Faire U; Hellenius M-L
Article: BMJ OPEN. 2020;10(8):e034613
Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme
Khunti K; Gomes MB; Kosiborod M; Nicolucci A; Pocock S; Rathmann W; Shestakova MV; Shimomura I; Watada H; Chen H; Cid-Ruzafa J; Fenici P; Hammar N; Tang F; Ji L
Article: JOURNAL OF ALZHEIMER'S DISEASE. 2020;76(4):1581-1594
Dementia Diagnosis Is Associated with Changes in Antidiabetic Drug Prescription: An Open-Cohort Study of ∼130,000 Swedish Subjects over 14 Years
Secnik J; Xu H; Schwertner E; Hammar N; Alvarsson M; Winblad B; Eriksdotter M; Garcia-Ptacek S; Religa D
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s70-s71
AS096 Repeated measures of FIB-4 improve prediction of severe liver disease: population-based cohort study of 40,729 individuals
Hagström H; Talbäck M; Andreasson A; Walldius G; Hammar N
Article: DIABETES RESEARCH AND CLINICAL PRACTICE. 2020;165:108250
Socioeconomic factors associated with hypoglycaemia in patients starting second-line glucose-lowering therapy: The DISCOVER study
Rathmann W; Charbonnel B; Gomes MB; Hammar N; Khunti K; Kosiborod M; Kuss O; Shestakova MV; Watada H; Shimomura I; Tang F; Cid-Ruzafa J; Chen H; Fenici P; Surmont F; Ji L
Article: BMJ OPEN DIABETES RESEARCH & CARE. 2020;8(1):e000833
Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ∼23 000 patients from the Swedish Dementia Registry
Secnik J; Schwertner E; Alvarsson M; Hammar N; Fastbom J; Winblad B; Garcia-Ptacek S; Religa D; Eriksdotter M
Article: FRONTIERS IN ONCOLOGY. 2020;10:263
Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study
Sollie S; Santaolalla A; Michaud DS; Sarker D; Karagiannis SN; Josephs DH; Hammar N; Walldius G; Garmo H; Holmberg L; Jungner I; Van Hemelrijck M
Article: DIABETES, OBESITY AND METABOLISM. 2020;22(1):66-78
Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme
Khunti K; Chen H; Cid-Ruzafa J; Fenici P; Gomes MB; Hammar N; Ji L; Kosiborod M; Pocock S; Shestakova MV; Shimomura I; Tang F; Watada H; Nicolucci A
Article: GASTROENTEROLOGY. 2020;158(1):200-214
Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease
Hagstrom H; Talback M; Andreasson A; Walldius G; Hammar N
Article: ANNALS OF NEUROLOGY. 2019;86(6):913-926
Peripheral immune biomarkers and neurodegenerative diseases: A prospective cohort study with 20 years of follow-up
Yazdani S; Mariosa D; Hammar N; Andersson J; Ingre C; Walldius G; Fang F
Article: DIABETES, OBESITY AND METABOLISM. 2019;21(11):2474-2485
Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme
Nicolucci A; Charbonnel B; Gomes MB; Khunti K; Kosiborod M; Shestakova MV; Shimomura I; Watada H; Chen H; Cid-Razufa J; Fenici P; Hammar N; Surmont F; Tang F; Pocock S
Journal article: EUROPEAN HEART JOURNAL. 2019;40(Supplement_1):ehz747.0056
209Glucose is associated with future atrial fibrillation and heart failure already at prediabetes levels, a 19 year follow up of 243,665 subjects
Lind V; Hammar N; Lundman P; Friberg L; Tallback M; Walldius G; Norhammar A
Article: CANCER EPIDEMIOLOGY. 2019;62:101584
Serum immunoglobulin levels and the risk of bladder cancer in the AMORIS Cohort
Peppas I; Sollie S; Josephs DH; Hammar N; Walldius G; Karagiannis SN; Van Hemelrijck M
Article: CIRCULATION RESEARCH. 2019;125(6):643-652
Lipids, Apolipoproteins, and the Risk of Parkinson Disease A Prospective Cohort Study and a Mendelian Randomization Analysis
Fang F; Zhan Y; Hammar N; Shen X; Wirdefeldt K; Walldius G; Mariosa D
Article: BMC CANCER. 2019;19(1):858
Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study
Sollie S; Michaud DS; Sarker D; Karagiannis SN; Josephs DH; Hammar N; Santaolalla A; Walldius G; Garmo H; Holmberg L; Jungner I; Van Hemelrijck M
Article: BMC MOLECULAR AND CELL BIOLOGY. 2019;20(1):28
Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
Santaolalla A; Garmo H; Grigoriadis A; Ghuman S; Hammar N; Jungner I; Walldius G; Lambe M; Holmberg L; Van Hemelrijck M
Journal article: ALZHEIMER'S AND DEMENTIA. 2019;15(7S_Part_22):p1186
P3‐554: CHOLINESTERASE INHIBITORS AND MORTALITY IN PATIENTS WITH DIABETES MELLITUS AND DEMENTIA: A COHORT STUDY OF ∼3,000 PATIENTS FROM THE SWEDISH DEMENTIA REGISTRY.
Secnik J; Schwertner E; Alvarsson M; Hammar N; Fastbom J; Winblad B; Garcia-Ptacek S; Religa D; Eriksdotter M
Article: ONCOIMMUNOLOGY. 2019;8(6):e1593811
Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma
Nakamura M; Bax HJ; Scotto D; Souri EA; Sollie S; Harris RJ; Hammar N; Walldius G; Winship A; Ghosh S; Montes A; Spicer JF; Van Hemelrijck M; Josephs DH; Lacy KE; Tsoka S; Karagiannis SN
Article: CANCER CAUSES AND CONTROL. 2019;30(6):603-615
Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort
Essen A; Santaolalla A; Garmo H; Hammar N; Walldius G; Jungner I; Malmstrom H; Holmberg L; Van Hemelrijck M
Article: DIABETES RESEARCH AND CLINICAL PRACTICE. 2019;151:20-32
Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study
Gomes MB; Rathmann W; Charbonnel B; Khunti K; Kosiborod M; Nicolucci A; Pocock SJ; Shestakova MV; Shimomura I; Tang F; Watada H; Chen H; Cid-Ruzafa J; Fenici P; Hammar N; Surmont F; Ji L
Journal article: JOURNAL OF HEPATOLOGY. 2019;70(1):e766-e767
SAT-297-Prediction of incident severe liver disease in the general population using non-invasive scoring systems
Hagström H; Talbäck M; Andreasson A; Carlsson A; Walldius G; Hammar N
Article: CANCER CAUSES AND CONTROL. 2019;30(2):195-206
Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study
Arthur R; Moller H; Garmo H; Haggstrom C; Holmberg L; Stattin P; Malmstrom H; Lambe M; Hammar N; Walldius G; Robinson D; Jungner I; Van Hemelrijck M
Article: ACTA ONCOLOGICA. 2019;58(1):110-118
Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study
Thomsen FB; Bosco C; Garmo H; Adolfsson J; Hammar N; Stattin P; Van Hemelrijck M
Journal article: FRONTIERS IN ONCOLOGY. 2019;9
Serum immunoglobulin levels and the risk of bladder cancer in the AMORIS Cohort
Peppas I; Sollie S; Josephs D; Hammar N; Walldius G; Karagiannis S; Van Hemelrijck M
Article: FRONTIERS IN ONCOLOGY. 2019;9:1095
Serum IgG Is Associated With Risk of Melanoma in the Swedish AMORIS Study
Kessler A; Sollie S; Karagiannis SN; Walldius G; Hammar N; Van Hemelrijck M
Article: BMJ OPEN DIABETES RESEARCH & CARE. 2019;7(1):e000627
Eligibility of patients with type 2 diabetes for sodium-glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study
Pintat S; Fenici P; Hammar N; Ji L; Khunti K; Medina J; Tang F; Wittbrodt E; Surmont F
Article: CARDIOVASCULAR DIABETOLOGY. 2018;17(1):150
Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program)
Kosiborod M; Gomes MB; Nicolucci A; Pocock S; Rathmann W; Shestakova MV; Watada H; Shimomura I; Chen H; Cid-Ruzafa J; Fenici P; Hammar N; Surmont F; Tang F; Khunti K
Article: BMC CANCER. 2018;18(1):1169
Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?
Ghoshal A; Garmo H; Hammar N; Jungner I; Malmstrom H; Walldius G; Van Hemelrijck M
Article: JOURNAL OF DIABETES AND ITS COMPLICATIONS. 2018;32(11):1035-1039
Assessing use of patient-focused pharmacotherapy in glycemic management through the Diabetes Collaborative Registry (DCR)
Arnold SV; McGuire DK; Lnzucchi SE; Tang F; Mehta SN; Lam CSP; Goyal A; Sperling LS; Wong ND; Hammar N; Fenici P; Kosiborod M
Journal article: EUROPEAN HEART JOURNAL. 2018;39(suppl_1):ehy563.p4389
P4389Favourable long-term effects of a cardiovascular prevention program in primary health care in Sweden in men, and women on first cardiovascular events, cardiovascular mortality, and all-cause mortality
Journath G; Hammar N; Hammar N; Vikstrom M; Linnersjo A; Linnersjo A; Walldius G; Krakau I; Lindgren P; Lindgren P; De Faire U; Hellenius ML
Article: DIABETES, OBESITY AND METABOLISM. 2018;20(8):1983-1987
Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study
Kosiborod M; Birkeland KI; Cavender MA; Fu AZ; Wilding JP; Khunti K; Holl RW; Norhammar A; Jorgensen ME; Wittbrodt ET; Thuresson M; Bodegard J; Hammar N; Fenici P
Article: BMC MEDICINE. 2018;16(1):116
Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink.
Wilding J; Godec T; Khunti K; Pocock S; Fox R; Smeeth L; Clauson P; Fenici P; Hammar N; Medina J
Journal article: DIABETES. 2018;67(Supplement_1)
Individualized HbA1c Targets in People with Type 2 Diabetes Initiating Second-Line Therapy—The Global DISCOVER Study
KHUNTI K; CHEN H; CID-RUZAFA J; FENICI P; GOMES MB; HAMMAR N; KENNEDY K; KOSIBOROD M; POCOCK S; SHESTAKOVA MV; SHIMOMURA I; SURMONT F; JI L
Journal article: DIABETES. 2018;67(Supplement_1)
Twelve-Month Changes in HbA1c, Fasting Plasma Glucose, and Weight among Patients with Type 2 Diabetes in 37 Countries—DISCOVER
CHARBONNEL B; BONNET F; CHEN H; CID-RUZAFA J; FENICI P; GOMES MB; HAMMAR N; JI L; KENNEDY K; KOSIBOROD M; POCOCK S; RATHMANN W; SHESTAKOVA MV; SHIMOMURA I; SURMONT F; KHUNTI K
Journal article: DIABETES. 2018;67(Supplement_1)
Vascular Events in Patients with Type 2 Diabetes in the Year following Initiation of Second-Line Therapy-The DISCOVER Study
KOSIBOROD M; CHEN H; CID-RUZAFA J; FENICI P; GOMES MB; KHUNTI K; POCOCK S; RATHMANN W; SHESTAKOVA MV; SHIMOMURA I; SURMONT F; TANG F; WATADA H; JI L; HAMMAR N
Journal article: DIABETES. 2018;67(Supplement_1)
Lower Risk of CV Events and Death Associated with Initiation of SGLT2 vs. DPP-4 Inhibitors—Analysis from the CVD-REAL 2 Study
KOHSAKA S; LAM CS; KIM DJ; KARASIK A; TANGRI N; GOH S-Y; THURESSON M; CHEN H; SURMONT F; HAMMAR N; FENICI P; KOSIBOROD M
Journal article: DIABETES. 2018;67(Supplement_1)
Temporal Trends in the Use of Sodium-Glucose Cotransporter 2 Inhibitors—The Global DISCOVER Study
KOSIBOROD M; CHEN H; CID-RUZAFA J; FENICI P; GOMES MB; HAMMAR N; KHUNTI K; POCOCK S; SHESTAKOVA MV; SHIMOMURA I; SURMONT F; TANG F; JI L
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2018;71(23):2628-2639
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs The CVD-REAL 2 Study
Kosiborod M; Lam CSP; Kohsaka S; Kim DJ; Karasik A; Shaw J; Tangri N; Goh S-Y; Thuresson M; Chen H; Surmont F; Hammar N; Fenici P
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2018;71(22):2497-2506
SGLT-2 Inhibitors and Cardiovascular Risk An Analysis of CVD-REAL
Cavender MA; Norhammar A; Birkeland KI; Jorgensen ME; Wilding JP; Khunti K; Fu AZ; Bodegard J; Blak BT; Wittbrodt E; Thuresson M; Fenici P; Hammar N; Kosiborod M
Journal article: ESMO OPEN. 2018;3(Suppl 2):a53-A259
PO-083 The role of the humoral immune system in pancreatic cancer
Sollie S; Michaud D; Sarker D; Karagiannis S; Josephs D; Hammar N; Santaolalla A; Walldius G; Junger I; Van Hemelrijck M
Journal article: ESMO OPEN. 2018;3(Suppl 2):a258-A259
PO-083 The role of the humoral immune system in pancreatic cancer
Sollie S; Michaud D; Sarker D; Karagiannis S; Josephs D; Hammar N; Santaolalla A; Walldius G; Junger I; Van Hemelrijck M
Article: DIABETES, OBESITY AND METABOLISM. 2018;20(6):1419-1426
Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes: Experience from the AMORIS study
Malmstrom H; Walldius G; Carlsson S; Grill V; Jungner I; Gudbjornsdottir S; Kosiborod M; Hammar N
Article: INTERNATIONAL JOURNAL OF CANCER. 2018;142(11):2254-2262
Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study
Arthur R; Williams R; Garmo H; Holmberg L; Stattin P; Malmstrom H; Lambe M; Hammar N; Walldius G; Robinsson D; Jungner I; Van Hemelrijck M
Journal article: CIRCULATION: CARDIOVASCULAR QUALITY AND OUTCOMES. 2018;11(suppl_1)
Abstract 261: Global Patterns of Comprehensive Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes Mellitus: Insights From the Global DISCOVER Registry
Patel KK; Charbonnel B; Chen H; Cid-Rufaza J; Fenici P; Hammar N; Ji L; Kennedy KF; Khunti K; Kosiborod M; Pocock S; Shestakova M; Shimomura I; Surmont F; Watada H; Gomes MB
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2018;17(2):e1089
755 Anti-androgen monotherapy versus GnRH agonists in men with non-metastatic prostate cancer
Thomsen FB; Bosco C; Garmo H; Adolfsson J; Hammar N; Stattin P; Van Hemelrijck M
Journal article: EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. 2018;44:s25
Serum inflammatory markers in relation to prostate cancer severity and death
Crawley D; Williams R; Garmo H; Holmberg L; Stattin P; Malmstrom H; Lambe M; Hammar N; Walldius G; Robinson D; Jungner I; Van Hemelrijck M
Article: DIABETES, OBESITY AND METABOLISM. 2018;20(3):667-671
Recent trends in the prevalence of type 2 diabetes and the association with abdominal obesity lead to growing health disparities in the USA: An analysis of the NHANES surveys from 1999 to 2014
Caspard H; Jabbour S; Hammar N; Fenici P; Sheehan JJ; Kosiborod M
Article: BMC CANCER. 2018;18(1):205
Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort
Bosco C; Garmo H; Hammar N; Walldius G; Jungner I; Malmstrom H; Holmberg L; Van Hemelrijck M
Article: BJU INTERNATIONAL. 2018;121(2):260-267
Drugs for metabolic conditions and prostate cancer death in men on GnRH agonists
Bosco C; Wong C; Garmo H; Crawley D; Holmberg L; Hammar N; Adolfsson J; Stattin P; Van Hemelrijck M
Article: DIABETES, OBESITY AND METABOLISM. 2018;20(2):389-399
Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10256 individuals from the United Kingdom and Germany
Khunti K; Godec TR; Medina J; Garcia-Alvarez L; Hiller J; Gomes MB; Cid-Ruzafa J; Charbonnel B; Fenici P; Hammar N; Hashigami K; Kosiborod M; Nicolucci A; Shestakova MV; Ji L; Pocock S
Article: ONCOTARGET. 2018;9(1):774-782
Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum
Ghoshal A; Garmo H; Arthur R; Carroll P; Holmberg L; Hammar N; Jungner I; Malmstrom H; Lambe M; Walldius G; Van Hemelrijck M
Article: PLOS ONE. 2018;13(8):e0201972
Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels - The AMORIS study
Ivert T; Malmstrom H; Hammar N; Carlsson AC; Wandell PE; Holzmann MJ; Jungner I; Arnlov J; Walldius G
Article: CLINICAL THERAPEUTICS. 2017;39(11):2296-2310.e14
Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries
Heintjes EM; Overbeek JA; Hall GC; Prieto-Alhambra D; Lapi F; Hammar N; Bezemer ID
Journal article: EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. 2017;43(11):2223-2224
Serum inflammatory markers in relation to prostate cancer severity and death
Crawley D; Williams R; Garmo H; Holmberg L; Stattin P; Malmstrom H; Lambe M; Hammar N; Walldius G; Robinson D; Jungner I; Van Hemelrijck M
Journal article: CANADIAN JOURNAL OF DIABETES. 2017;41(5):s51-s52
127 Hospitalization for Heart Failure and Death in New Users of SGLT-2 Inhibitors in Patients With and Without Cardiovascular Disease—CVD Real Study
Cavender MA; Norhammar A; Birkeland KI; Jorgensen ME; Wilding JPH; Khunti K; Fu AZ; Bodegard J; Blak BT; Wittbrodt ET; Thuresson M; Fenici P; Hammar N; Kosiborod MN
Article: INTERNATIONAL JOURNAL OF CANCER. 2017;141(6):1148-1160
The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort
Nderitu P; Bosco C; Garmo H; Holmberg L; Malmstrom H; Hammar N; Walldius G; Jungner I; Ross P; Van Hemelrijck M
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2017;6(8):e005999
Quality of Care of the Initial Patient Cohort of the Diabetes Collaborative Registry®.
Arnold SV; Goyal A; Inzucchi SE; McGuire DK; Tang F; Mehta SN; Sperling LS; Maddox TM; Einhorn D; Wong ND; Hammar N; Fenici P; Khunti K; Lam CSP; Kosiborod M
Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2017;46(4):1103-1103i
Cohort Profile: The AMORIS cohort
Walldius G; Malmstrom H; Jungner I; de Faire U; Lambe M; Van Hemelrijck M; Hammar N
Article: CIRCULATION. 2017;136(3):249-259
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)
Kosiborod M; Cavender MA; Fu AZ; Wilding JP; Khunti K; Holl RW; Norhammar A; Birkeland KI; Jorgensen ME; Thuresson M; Arya N; Bodegard J; Hammar N; Fenici P
Article: JOURNAL OF DIABETES AND ITS COMPLICATIONS. 2017;31(7):1188-1196
Towards an improved global understanding of treatment and outcomes in people with type 2 diabetes: Rationale and methods of the DISCOVER observational study program
Ji L; Bonnet F; Charbonnel B; Gomes MB; Kosiborod M; Khunti K; Nicolucci A; Pocock S; Rathmann W; Shestakova MV; Shimomura I; Watada H; Fenici P; Hammar N; Hashigami K; Macaraeg G; Surmont F; Medina J
Article: ONCOTARGET. 2017;8(26):42332-42342
Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study
Yiu A; Van Hemelrijck M; Garmo H; Holmberg L; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Wulaningsih W
Article: STATISTICS IN MEDICINE. 2017;36(13):2100-2119
A latent class model for competing risks
Rowley M; Garmo H; Van Hemelrijck M; Wulaningsih W; Grundmark B; Zethelius B; Hammar N; Walldius G; Inoue M; Holmberg L; Coolen ACC
Article: BRITISH JOURNAL OF CANCER. 2017;116(10):1358-1365
Serum inflammatory markers and colorectal cancer risk and survival
Ghuan S; Van Hemelrijck M; Garmo H; Holmberg L; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Wulaningsih W
Article: SCIENTIFIC REPORTS. 2017;7(1):1436
Associations between prediagnostic blood glucose levels, diabetes, and glioma
Schwartzbaum J; Edlinger M; Zigmont V; Stattin P; Rempala GA; Nagel G; Hammar N; Ulmer H; Foeger B; Walldius G; Manjer J; Malmstrom H; Feychting M
Article: ANNALS OF NEUROLOGY. 2017;81(5):718-728
Blood Biomarkers of Carbohydrate, Lipid, and Apolipoprotein Metabolisms and Risk of Amyotrophic Lateral Sclerosis: A More Than 20-Year Follow-up of the Swedish AMORIS Cohort
Mariosa D; Hammar N; Malmstrom H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
Article: BMC CANCER. 2017;17(1):246
Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort
Melvin JC; Garmo H; Holmberg L; Hammar N; Walldius G; Jungner I; Lambe M; Van Hemelrijck M
Article: CLINICAL THERAPEUTICS. 2017;39(4):759-770
Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-based Multi -database Study
Overbeek JA; Heintjes EM; Prieto-Alhambra D; Blin P; Lassalle R; Hall GC; Lapi F; Bianchini E; Hammar N; Bezemer ID; Herings RMC
Article: BREAST CANCER RESEARCH. 2017;19(1):22
Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort
Shackshaft L; Van Hemelrijck M; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Wulaningsih W
Article: DIABETES RESEARCH AND CLINICAL PRACTICE. 2017;125:29-38
Early drug use of dapagliflozin prescribed by general practitioners and diabetologists in Germany
Hankins M; Tsai K; Kim J; Hammar N
Article: ECANCERMEDICALSCIENCE. 2017;11:762
Serum biomarkers to predict risk of testicular and penile cancer in AMORIS.
Ghoshal A; Garmo H; Arthur R; Hammar N; Jungner I; Malmström H; Lambe M; Walldius G; Hemelrijck MV
Article: DIABETES AND VASCULAR DISEASE RESEARCH. 2017;14(1):24-32
Patient characteristics related to metabolic disorders and chronic complications in type 2 diabetes mellitus patients hospitalized at the Qingdao Endocrine and Diabetes Hospital from 2006 to 2012 in China
Dong Y; Gao W; Zhang L; Wei J; Hammar N; Cabrera CS; Wu X; Qiao Q
Article: NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES. 2016;26(12):1120-1128
Low fructosamine and mortality - A long term follow-up of 215,011 non-diabetic subjects in the Swedish AMORIS study
Malmstrom H; Wandell PE; Holzmann MJ; Arnlov J; Jungner I; Hammar N; Walldius G; Carlsson AC
Journal article: EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. 2016;42(11):s231
Association between metabolic syndrome components and the risk of primary liver cancer and cirrhosis
Nderitu P; Garmo H; Holmberg L; Malmstrom H; Hammar N; Walldius G; Jungner I; Lambe M; Van Hemelrijck M
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2016;17(9):E1487-1487
Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies
Wulaningsih W; Sagoo HK; Hamza M; Melvin J; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Van Hemelrijck M
Article: ATHEROSCLEROSIS. 2016;251:85-93
Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study
Rohrmann S; Garmo H; Malmstrom H; Hammar N; Jungner I; Walldius G; Van Hemelrijck M
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (EJPC). 2016;23(11):1187-1194
Chronic kidney disease and 10-year risk of cardiovascular death
Holzmann MJ; Carlsson AC; Hammar N; Ivert T; Walldius G; Jungner I; Wandell P; Arnlov J
Article: BRITISH JOURNAL OF CANCER. 2016;115(1):108-114
Association between prediagnostic glucose, triglycerides, cholesterol and meningioma, and reverse causality
Bernardo BM; Orellana RC; Weisband YL; Hammar N; Walldius G; Malmstrom H; Ahlbom A; Feychting M; Schwartzbaum J
Article: ONCOIMMUNOLOGY. 2016;5(6):e1154250
Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival
Wulaningsih W; Holmberg L; Garmo H; Karagiannis SN; Ahlstedt S; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Ng T; Van Hemelrijck M
Article: CANCER MEDICINE. 2016;5(6):1307-1318
Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories
Arthur R; Moller H; Garmo H; Holmberg L; Stattin P; Malmstrom H; Lambe M; Hammar N; Walldius G; Robinson D; Jungner I; Van Hemelrijck M
Article: CURRENT MEDICAL RESEARCH AND OPINION. 2016;32(4):703-711
Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population
Kern DM; Mellstrom C; Hunt PR; Tunceli O; Wu B; Westergaard M; Hammar N
Article: CLINICAL DRUG INVESTIGATION. 2016;36(3):225-233
Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting
Hasvold P; Thuresson M; Sundstrom J; Hammar N; Kjeldsen SE; Johansson G; Holme I; Bodegard J
Article: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 2016;70(1):45-55
Weight change and healthcare resource use in English patients with type 2 diabetes mellitus initiating a new diabetes medication class.
Blak BT; Rigney U; Sternhufvud C; Davis J; Hammar N
Journal article: ANNALS OF ONCOLOGY. 2015;26:ix8
42P Atopy and cancer risk: Insights from a prospective study on serum specific and total immunoglobulin E
Wulaningsih W; Garmo H; Holmberg L; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; van Hemelrijck M
Article: BMC CANCER. 2015;15:913
Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis
Wulaningsih W; Vahdaninia M; Rowley M; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Coolen AC; Van Hemelrijck M
Article: BRITISH JOURNAL OF CANCER. 2015;113(9):1389-1396
Serum lactate dehydrogenase and survival following cancer diagnosis
Wulaningsih W; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Ng T; Van Hemelrijck M
Article: CARCINOGENESIS. 2015;36(10):1121-1128
Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients
Wulaningsih W; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Van Hemelrijck M
Article: NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES. 2015;25(10):943-950
Fructosamine is a risk factor for myocardial infarction and all-cause mortality - Longitudinal experience from the AMORIS cohort
Malmstrom H; Walldius G; Grill V; Jungner I; Hammar N
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (EJPC). 2015;22(3):304-311
Disability pension after coronary revascularization: a prospective nationwide register-based Swedish cohort study
Zetterstroem K; Vaez M; Alexanderson K; Ivert T; Pehrsson K; Hammar N; Voss M
Article: JOURNAL OF DIABETES AND METABOLIC DISORDERS. 2015;15:28
Effectiveness of sulphonylureas in the therapy of diabetes mellitus type 2 patients: an observational cohort study.
Wilke T; Mueller S; Groth A; Berg B; Hammar N; Tsai K; Fuchs A; Stephens S; Maywald U
Article: PLOS ONE. 2015;10(8):e0135277
Disability Pension at the Time of Coronary Revascularisation Is Associated with Higher Five-Year Mortality; A Swedish Nationwide, Register-Based Prospective Cohort Study
Zetterstrom K; Voss M; Alexanderson K; Ivert T; Pehrsson K; Hammar N; Vaez M
Article: PLOS ONE. 2015;10(11):e0140201
Time Trends in Incidence and Mortality of Acute Myocardial Infarction, and All-Cause Mortality following a Cardiovascular Prevention Program in Sweden
Journath G; Hammar N; Elofsson S; Linnersjo A; Vikstrom M; Walldius G; Krakau I; Lindgren P; de Faire U; Hellenius M-L
Article: PLOS ONE. 2015;10(1):e0115540
Prevalence of All-Cause and Diagnosis-Specific Disability Pension at the Time of First Coronary Revascularisation: A Population-Based Swedish Cross-Sectional Study
Zetterstrom K; Voss M; Alexanderson K; Ivert T; Pehrsson K; Hammar N; Vaez M
Article: JOURNAL OF HUMAN HYPERTENSION. 2014;28(11):663-669
Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients
Hasvold LP; Bodegard J; Thuresson M; Stalhammar J; Hammar N; Sundstrom J; Russell D; Kjeldsen SE
Journal article: EUROPEAN JOURNAL OF PUBLIC HEALTH. 2014;24(suppl_2):cku166-cku037
Prevalence of all-cause and diagnosis-specific disability pension at the time of first coronary revascularization among women and men in Sweden: A population-based cross-sectional study
Zetterström K; Voss M; Alexanderson K; Ivert T; Pehrsson K; Hammar N; Vaez M
Journal article: VALUE IN HEALTH. 2014;17(3):a106-a107
PCV29 Rates Of Acute Coronary Events And All Cause Mortality In Patients With Stable Coronary Artery Disease (Cad) After Myocardial Infarction And Additional Cardiovascular Risk Factors
DeVore S; Mellstrom C; Hunt PR; Kern DM; Tunceli O; Wu B; Westergaard M; Hammar N
Journal article: VALUE IN HEALTH. 2014;17(3):a110
PCV49 Long Term Health Care Costs For Patients With Stable Coronary Artery Disease (Cad) After Myocardial Infarction In The United States
Mellstrom C; Hunt PR; Kern DM; Westergaard M; Wu B; Tunceli O; Hammar N; DeVore S
Journal article: VALUE IN HEALTH. 2014;17(3):a252
PDB84 Weight change and health care resource use (HCRU) in english patients with type 2 diabetes mellitus (T2DM) initiating a new antidiabetic drug class
Rigney U; Blak BT; Sternhufvud C; Ycas J; Racketa J; Hammar N
Article: OCCUPATIONAL AND ENVIRONMENTAL MEDICINE. 2014;71(5):313-322
Mortality from cancer and other causes in commercial airline crews: a joint analysis of cohorts from 10 countries
Hammer GP; Auvinen A; De Stavola BL; Grajewski B; Gundestrup M; Haldorsen T; Hammar N; Lagorio S; Linnersjo A; Pinkerton L; Pukkala E; Rafnsson V; dos-Santos-Silva I; Storm HH; Strand T-E; Tzonou A; Zeeb H; Blettner M
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2014;172(1):190-195
Acute kidney injury after coronary artery bypass grafting and long-term risk of myocardial infarction and death
Ryden L; Ahnve S; Bell M; Hammar N; Ivert T; Sartipy U; Holzmann MJ
Journal article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2014;12(1):159
Serum Glucose and Lipids in Relation to Gastrointestinal Cancer Risk
Wulaningsih W; Garmo H; Holmberg L; Hammar N; Jungner I; Walldius G; Van Hemelrijck M
Article: PLOS ONE. 2014;9(10):e111463
Fructosamine Is a Useful Indicator of Hyperglycaemia and Glucose Control in Clinical and Epidemiological Studies - Cross-Sectional and Longitudinal Experience from the AMORIS Cohort
Malmstrom H; Walldius G; Grill V; Jungner I; Gudbjornsdottir S; Hammar N
Journal article: VALUE IN HEALTH. 2013;16(7):a432
PDB6 Baseline Characteristics, Weight and Glycaemic Change Among Patients in the United Kingdom with Type 2 Diabetes Mellitus (T2DM) Prescribed a New Antidiabetic Treatment Class in a Real World Setting
Blak BT; Rigney U; Ycas J; Racketa J; Hammar N
Article: EUROPEAN JOURNAL OF PUBLIC HEALTH. 2013;23(4):594-605
Sizable variations in circulatory disease mortality by region and country of birth in six European countries
Rafnsson SB; Bhopal RS; Agyemang C; Fagot-Campagna A; Harding S; Hammar N; Hedlund E; Juel K; Primatesta P; Rosato M; Rey G; Wild SH; Mackenbach JP; Stirbu I; Kunst AE
Article: BMC PUBLIC HEALTH. 2013;13:663
Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study
Wulaningsih W; Michaelsson K; Garmo H; Hammar N; Jungner I; Walldius G; Lambe M; Holmberg L; Van Hemelrijck M
Article: CANCER CAUSES AND CONTROL. 2013;24(7):1393-1402
Iron metabolism and risk of cancer in the Swedish AMORIS study
Gaur A; Collins H; Wulaningsih W; Holmberg L; Garmo H; Hammar N; Walldius G; Jungner I; Van Hemelrijck M
Journal article: ANNALS OF ONCOLOGY. 2013;24:iv18
O-0019 Serum Calcium and Risk of Gastrointestinal Cancer
Wulaningsih W; Michaelsson K; Garmo H; Hammar N; Jungner I; Walldius G; Lambe M; Holmberg L; Van Hemelrijck M
Article: DIABETES RESEARCH AND CLINICAL PRACTICE. 2013;100(3):404-408
Country of birth-specific and gender differences in prevalence of diabetes in Sweden
Carlsson AC; Wandell PE; Hedlund E; Walldius G; Nordqvist T; Jungner I; Hammar N
Article: BMC CANCER. 2013;13:257
Inorganic phosphate and the risk of cancer in the Swedish AMORIS study
Wulaningsih W; Michaelsson K; Garmo H; Hammar N; Jungner I; Walldius G; Holmberg L; Van Hemelrijck M
Article: PLOS ONE. 2013;8(1):e54944
Serum Glucose and Fructosamine in Relation to Risk of Cancer
Wulaningsih W; Holmberg L; Garmo H; Zethelius B; Wigertz A; Carroll P; Lambe M; Hammar N; Walldius G; Jungner I; Van Hemelrijck M
Article: INTERNATIONAL JOURNAL OF CANCER. 2012;131(12):2886-2897
Cancer incidence among Nordic airline cabin crew
Pukkala E; Helminen M; Haldorsen T; Hammar N; Kojo K; Linnersjo A; Rafnsson V; Tulinius H; Tveten U; Auvinen A
Article: JOURNAL OF DIABETES AND ITS COMPLICATIONS. 2012;26(6):501-505
Incidence of genital infection among patients with type 2 diabetes in the UK General Practice Research Database.
Hirji I; Andersson SW; Guo Z; Hammar N; Gomez-Caminero A
Article: JOURNAL OF DIABETES AND ITS COMPLICATIONS. 2012;26(6):513-516
Incidence of urinary tract infection among patients with type 2 diabetes in the UK General Practice Research Database (GPRD).
Hirji I; Guo Z; Andersson SW; Hammar N; Gomez-Caminero A
Article: ANNALS OF MEDICINE. 2012;44(6):607-615
Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population
Holzmann MJ; Aastveit A; Hammar N; Jungner I; Walldius G; Holme I
Article: ANNALS OF MEDICINE. 2012;44(5):476-486
High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114,159 healthy men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Holme I; Aastveit AH; Hammar N; Jungner I; Walldius G
Article: CANCER CAUSES AND CONTROL. 2012;23(8):1349-1358
Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study
Van Hemelrijck M; Hermans R; Michaelsson K; Melvin J; Garmo H; Hammar N; Jungner I; Walldius G; Holmberg L
Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2012;21(8):1381-1384
Lipid Profiles and Risk of Breast and Ovarian Cancer in the Swedish AMORIS Study
Melvin JC; Seth D; Holmberg L; Garmo H; Hammar N; Jungner I; Walldius G; Lambe M; Wigertz A; Van Hemelrijck M
Article: EUROPEAN JOURNAL OF PUBLIC HEALTH. 2012;22(3):353-359
Mortality from circulatory diseases by specific country of birth across six European countries: test of concept
Bhopal RS; Rafnsson SB; Agyemang C; Fagot-Campagna A; Giampaoli S; Hammar N; Harding S; Hedlund E; Juel K; Mackenbach JP; Primatesta P; Rey G; Rosato M; Wild S; Kunst AE
Article: ANNALS OF MEDICINE. 2012;44(3):262-270
Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease
Holzmann MJ; Jungner I; Walldius G; Ivert T; Nordqvist T; Ostergren J; Hammar N
Article: INTERNATIONAL JOURNAL OF CANCER. 2012;130(9):2118-2128
The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study
Van Hemelrijck M; Garmo H; Hammar N; Jungner I; Walldius G; Lambe M; Holmberg L
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2012;46(2):114-120
Acute kidney injury following coronary artery bypass grafting: early mortality and postoperative complications
Ryden L; Ahnve S; Bell M; Hammar N; Ivert T; Holzmann MJ
Article: INTERNATIONAL JOURNAL OF MOLECULAR EPIDEMIOLOGY AND GENETICS. 2012;3(4):276-285
Gamma-glutamyl transferase and C-reactive protein as alternative markers of metabolic abnormalities and their associated comorbidites: a prospective cohort study.
Melvin JC; Rodrigues C; Holmberg L; Garmo H; Hammar N; Jungner I; Walldius G; Lambe M; Jassem W; Van Hemelrijck M
Article: INTERNATIONAL JOURNAL OF MOLECULAR EPIDEMIOLOGY AND GENETICS. 2012;3(1):66-76
Biomarker-based score to predict mortality in persons aged 50 years and older: a new approach in the Swedish AMORIS study.
Van Hemelrijck M; Harari D; Garmo H; Hammar N; Walldius G; Lambe M; Jungner I; Holmberg L
Article: INTERNATIONAL JOURNAL OF MOLECULAR EPIDEMIOLOGY AND GENETICS. 2012;3(2):122-133
Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study.
Seth D; Garmo H; Wigertz A; Holmberg L; Hammar N; Jungner I; Lambe M; Walldius G; Van Hemelrijck M
Article: JOURNAL OF CANCER EPIDEMIOLOGY. 2012;2012:792034-10
Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study.
Wulaningsih W; Garmo H; Holmberg L; Hammar N; Jungner I; Walldius G; Van Hemelrijck M
Article: PLOS ONE. 2012;7(7):e40952
Sickness Absence following Coronary Revascularisation. A National Study of Women and Men of Working Age in Sweden 1994-2006
Voss M; Ivert T; Pehrsson K; Hammar N; Alexanderson K; Nilsson T; Vaez M
Article: INTERNATIONAL JOURNAL OF CANCER. 2011;129(6):1485-1492
Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation
Van Hemelrijck M; Jungner I; Walldius G; Garmo H; Binda E; Hayday A; Lambe M; Holmberg L; Hammar N
Article: EUROPEAN HEART JOURNAL. 2011;32(18):2290-2296
Childhood appendectomy, tonsillectomy, and risk for premature acute myocardial infarction-a nationwide population-based cohort study
Janszky I; Mukamal KJ; Dalman C; Hammar N; Ahnve S
Article: EUROPEAN JOURNAL OF CANCER. 2011;47(13):2033-2041
Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study
Van Hemelrijck M; Jassem W; Walldius G; Fentiman IS; Hammar N; Lambe M; Garmo H; Jungner I; Holmberg L
Article: CANCER CAUSES AND CONTROL. 2011;22(8):1163-1171
Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer
Lambe M; Wigertz A; Garmo H; Walldius G; Jungner I; Hammar N
Article: CANCER CAUSES AND CONTROL. 2011;22(7):1011-1019
Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study
Van Hemelrijck M; Walldius G; Jungner I; Hammar N; Garmo H; Binda E; Hayday A; Lambe M; Holmberg L
Article: CANCER. 2011;117(10):2086-2095
Prostate Cancer Risk in the Swedish AMORIS Study The Interplay Among Triglycerides, Total Cholesterol, and Glucose
Van Hemelrijck M; Garmo H; Holmberg L; Walldius G; Jungner I; Hammar N; Lambe M
Article: SCANDINAVIAN JOURNAL OF WORK, ENVIRONMENT & HEALTH. 2011;37(3):219-226
Low mortality and myocardial infarction incidence among flying personnel during working career and beyond
Linnersjo A; Brodin L-A; Andersson C; Alfredsson L; Hammar N
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2011;148(1):64-69
Analysis of ST/HR hysteresis improves long-term prognostic value of exercise ECG test
Kronander H; Hammar N; Fischer-Colbrie W; Nowak J; Brodin L-A; Elmqvist H
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2011;10(2):207
639 RISK OF PROSTATE CANCER IS NOT ASSOCIATED WITH LEVELS OF C-REACTIVE PROTEIN AND OTHER COMMONLY USED MARKERS OF INFLAMMATION
Van HMJJ; Jugner I; Walldius G; Garmo H; Binda E; Hayday A; Lambe M; Holmberg L; Hammar N
Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2011;20(3):428-437
Association between Levels of C-Reactive Protein and Leukocytes and Cancer: Three Repeated Measurements in the Swedish AMORIS Study
Van Hemelrijck M; Holmberg L; Garmo H; Hammar N; Walldius G; Binda E; Lambe M; Jungner I
Journal article: INTERNATIONAL JOURNAL OF OBESITY. 2011;35(2):313-314
Erratum: Ethnic comparison of the association of undiagnosed diabetes with obesity
Nyamdorj R; Pitkäniemi J; Tuomilehto J; Hammar N; Stehouwer CDA; Lam TH; Ramachandran A; Janus ED; Mohan V; Söderberg S; Laatikainen T; Gabriel R; Qiao Q
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2010;19(12):1287-1292
Incidence of urinary tract infection in patients with type 2 diabetes. Experience from adverse event reporting in clinical trials
Hammar N; Farahmand B; Gran M; Joelson S; Andersson SW
Article: ATHEROSCLEROSIS. 2010;213(1):299-305
Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Holme I; Aastveit AH; Hammar N; Jungner I; Walldius G
Article: CANCER CAUSES AND CONTROL. 2010;21(10):1657-1667
Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study
Van Hemelrijck M; Garmo H; Binda E; Hayday A; Karagiannis SN; Hammar N; Walldius G; Lambe M; Jungner I; Holmberg L
Article: DIABETES/METABOLISM RESEARCH AND REVIEWS. 2010;26(4):245-253
Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities?
Ning F; Qiao Q; Tuomilehto J; Hammar N; Ho SY; Soderberg S; Zimmet PZ; Shaw JE; Nakagami T; Mohan V; Ramachandran A; Lam TH; Andersson SW; Janus ED; Boyko EJ; Fujimoto WY; Pang ZC
Article: EUROPEAN HEART JOURNAL. 2010;31(8):967-975
Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation
Friberg L; Hammar N; Rosenqvist M
Article: JOURNAL OF INTERNAL MEDICINE. 2010;267(4):357-369
Renal function assessed by two different formulas and incidence of myocardial infarction and death in middle-aged men and women
Holzmann MJ; Ivert T; Jungner I; Nordqvist T; Walldius G; Ostergren J; Hammar N
Journal article: INTERNATIONAL JOURNAL OF OBESITY. 2010;34(3):597
Erratum: Ethnic comparison of the association of undiagnosed diabetes with obesity
Nyamdorj R; Pitkäniemi J; Tuomilehto J; Hammar N; Stehouwer CDA; Lam TH; Ramachandran A; Janus ED; Mohan V; Söderberg S; Laatikainen T; Gabriel R; Qiao Q
Article: HEART. 2010;96(4):275-280
Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF)
Friberg L; Hammar N; Rosenqvist M
Article: INTERNATIONAL JOURNAL OF OBESITY. 2010;34(2):332-339
Ethnic comparison of the association of undiagnosed diabetes with obesity
Nyamdorj R; Pitkaniemi J; Tuomilehto J; Hammar N; Stehouwer CDA; Lam TH; Ramachandran A; Janus ED; Mohan V; Soderberg S; Laatikainen T; Gabriel R; Qiao Q
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2010;138(1):50-55
Insulin-like growth factor binding protein-1 is a long-term predictor of heart failure in survivors of a first acute myocardial infarction and population controls
Janszky I; Hallqvist J; Ljung R; Hammar N
Article: JOURNAL OF INTERNAL MEDICINE. 2009;266(6):558-570
Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Holme I; Aastveit AH; Hammar N; Jungner I; Walldius G
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2009;11(11):1036-1042
Lipoprotein components and risk of congestive heart failure in 84 740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Holme I; Aastveit AH; Hammar N; Jungner I; Walldius G
Article: JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. 2009;138(5):1115-1122
Improved survival after coronary artery bypass grafting has not influenced the mortality disadvantage in patients with diabetes mellitus
Alserius T; Hammar N; Nordqvist T; Ivert T
Article: ATHEROSCLEROSIS. 2009;206(1):298-302
The impact of dyslipidaemia on cardiovascular mortality in individuals without a prior history of diabetes in the DECODE Study
Zhang L; Qiao Q; Tuomilehto J; Hammar N; Ruotolo G; Stehouwer CDA; Heine RJ; Eliasson M; Zethelius B
Article: DIABETIC MEDICINE. 2009;26(9):855-863
Risk factors associated with the dramatic increase in the prevalence of diabetes in the adult Chinese population in Qingdao, China
Ning F; Pang ZC; Dong YH; Gao WG; Nan HR; Wang SJ; Zhang L; Ren J; Tuomilehto J; Hammar N; Malmberg K; Andersson SW; Qiao Q
Article: DIABETES/METABOLISM RESEARCH AND REVIEWS. 2009;25(6):549-557
Blood lipid levels in relation to glucose status in seven populations of Asian origin without a prior history of diabetes: the DECODA study
Zhang L; Qiao Q; Tuomilehto J; Hammar N; Janus ED; Soderberg S; Mohan V; Ramachandran A; Dong YH; Lam TH; Pang ZC
Article: HEART. 2009;95(12):1000-1005
The prognosis of patients with atrial fibrillation is improved when sinus rhythm is restored: report from the Stockholm Cohort of Atrial Fibrillation (SCAF)
Friberg L; Hammar N; Edvardsson N; Rosenqvist M
Article: JOURNAL OF INTERNAL MEDICINE. 2009;265(4):465-475
Prognostic role of the glucometabolic status assessed in a metabolically stable phase after a first acute myocardial infarction: the SHEEP study
Janszky I; Hallqvist J; Ljung R; Ahlbom A; Hammar N
Article: EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2009;63(3):312-322
Migration and differences in dietary habits-a cross sectional study of Finnish twins in Sweden
Hammar N; Hakala P; Jorgensen L; Becker W; Hedlund E; Ronnemaa T; Koskenvuo M; Kaprio J
Article: AMERICAN HEART JOURNAL. 2009;157(3):495-501
Coffee consumption and mortality after acute myocardial infarction: The Stockholm Heart Epidemiology Program
Mukamal KJ; Hallqvist J; Hammar N; Ljung R; Gemes K; Ahlbom A; Ahnve S; Janszky I
Article: JOURNAL OF INTERNAL MEDICINE. 2009;265(3):345-358
Migration at early age from a high to a lower coronary heart disease risk country lowers the risk of subclinical atherosclerosis in middle-aged men
Jartti L; Ronnemaa T; Raitakari OT; Hedlund E; Hammar N; Lassila R; Marniemi J; Koskenvuo M; Kaprio J
Article: JOURNAL OF INTERNAL MEDICINE. 2009;265(2):275-287
Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS)
Holme I; Aastveit AH; Hammar N; Jungner I; Walldius G
Article: ANNALS OF MEDICINE. 2009;41(7):522-532
Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Holme I; Aastveit AH; Hammar N; Jungner I; Walldius G
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2008;42(6):392-398
Elevated glycosylated haemoglobin (HbA1c) is a risk marker in coronary artery bypass surgery
Alserius T; Anderson RE; Hammar N; Nordqvist T; Ivert T
Article: DIABETES RESEARCH AND CLINICAL PRACTICE. 2008;82(3):364-377
Blood lipid levels in relation to glucose status in European men and women without a prior history of diabetes: The DECODE Study
Zhang L; Qiao Q; Tuomilehto J; Hammar N; Alberti KGMM; Eliasson M; Heine RJ; Stehouwer CDA; Ruotolo G
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2008;42(5):323-326
Grade of left main coronary artery stenosis does not influence long-term mortality after coronary artery bypass surgery
Jonsson A; Ivert T; Nordqvist T; Hammar N
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2008;36(5):546-554
Time trends in incidence of myocardial infarction in male and female dominated occupations in Stockholm, Sweden
Ostlin P; Klerdal K; Hammar N
Article: EUROPEAN JOURNAL OF PUBLIC HEALTH. 2008;18(2):150-155
Selective international migration by social position, health behaviour and personality
Silventoinen K; Hammar N; Hedlund E; Koskenvuo M; Ronnemaa T; Kaprio J
Article: JOURNAL OF CARDIOVASCULAR RISK. 2008;15(1):83-88
Serum lipids, blood pressure and body weight around the age of the menopause
Graff-Iversen S; Thelle DS; Hammar N
Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY (EJE). 2008;23(5):341-347
Country of birth and survival after a first myocardial infarction in Stockholm, Sweden
Hedlund E; Pehrsson K; Lange A; Hammar N
Article: JOURNAL OF CARDIOVASCULAR RISK. 2007;14:S23-S41
Population-based register of stroke: manual of operations
Giampaoli S; Hammar N; Adany R; De Peretti C
Article: EUROPEAN HEART JOURNAL. 2007;28(19):2346-2353
Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF)
Friberg L; Hammar N; Pettersson H; Rosenqvist M
Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY (EJE). 2007;22(8):493-503
Acute myocardial infarction incidence in immigrants to Sweden. Country of birth, time since immigration, and time trends over 20 years
Hedlund E; Lange A; Hammar N
Article: SCANDINAVIAN JOURNAL OF WORK, ENVIRONMENT & HEALTH. 2007;33(4):267-271
Myocardial infarction in Swedish subway drivers
Bigert C; Klerdal K; Hammar N; Gustavsson P
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2007;16(7):726-735
The new Swedish Prescribed Drug Register -: Opportunities for pharmacoepidemiological research and experience from the first six months
Wettermark B; Harnmar N; MichaelFored C; Leimanis A; Olausson PO; Bergman U; Persson I; Sundstrom A; Westerholm B; Rosen M
Article: DIABETES RESEARCH AND CLINICAL PRACTICE. 2007;76(1):57-67
Prevalence of the metabolic syndrome in populations of Asian origin. Comparison of the IDF definition with the NCEP definition.
DECODA Study Group
Article: EUROPEAN HEART JOURNAL. 2007;28(7):865-871
Renal insufficiency and long-term mortality and incidence of myocardial infarction in patients undergoing coronary artery bypass grafting
Holzmann MJ; Hammar N; Ahnve S; Nordqvist T; Pehrsson K; Ivert T
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2007;35(5):468-474
Migration and coronary heart disease: A study of Finnish twins living in Sweden and their co-twins residing in Finland.
Hedlund E; Kaprio J; Lange A; Koskenvuo M; Jartti L; Rönnemaa T; Hammar N
Article: AMERICAN HEART JOURNAL. 2006;152(3):599-605
Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes
Alserius T; Hammar N; Nordqvist T; Ivert T
Article: EUROPEAN HEART JOURNAL. 2006;27(16):1954-1964
Stroke prophylaxis in atrial fibrillation: who gets it and who does not?
Friberg L; Hammar N; Ringh M; Pettersson H; Rosenqvist M
Article: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2006;30(2):311-317
Left main coronary artery stenosis no longer a risk factor for early and late death after coronary artery bypass surgery -: an experience covering three decades
Jonsson A; Hammar N; Nordquist T; Ivert T
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2006;40(3):179-185
High mortality after coronary bypass surgery in patients with high-grade left main coronary artery stenosis
Jonsson A; Hammar N; Liska J; Nordqvist T; Ivert T
Article: JOURNAL OF ETHNIC AND MIGRATION STUDIES. 2006;32(1):3-28
Migrating twins:: A study of welfare components among Finnish twins living in Sweden and their co-twins residing in Finland
Hedlund E; Hammar N; Lange A; Koskenvuo M; Jörgensen L; Kaprio J
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2006;34(1):11-16
Use of oral contraceptives and mortality during 14 years' follow-up of Norwegian women
Graff-Iversen S; Hammar N; Thelle DS; Tonstad S
Journal article: ACC CARDIOSOURCE REVIEW JOURNAL. 2005;14(12):48
Are Even Impaired Fasting Blood Glucose Levels Preoperatively Associated With Increased Mortality After CABG Surgery?
Anderson RE; Klerdal K; Ivert T; Hammar N; Barr G; Öwall A
Article: JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. 2005;130(3):746-752
Creatinine clearance and risk of early mortality in patients undergoing coronary artery bypass grafting
Holzmann MJ; Ahnve S; Hammar N; Jörgensen L; Klerdal K; Pehrsson K; Ivert T
Article: JOURNAL OF INTERNAL MEDICINE. 2005;258(2):124-132
Cancer risk of patients with ischaemic syndromes
Pehrsson SK; Linnersjö A; Hammar N
Article: EUROPEAN HEART JOURNAL. 2005;26(15):1513-1518
Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery?
Anderson RE; Klerdal K; Ivert T; Hammar N; Barr G; Öwall A
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2005;33(4):285-291
Migration and smoking:: An epidemiological study of Finnish twins in Sweden
Jörgensen L; Hammar N; Kaprio J; Koskenvuo M; Svensson Å
Article: OCCUPATIONAL AND ENVIRONMENTAL MEDICINE. 2004;61(12):987-991
Time trends in the incidence of myocardial infarction among professional drivers in Stockholm 1977-96
Bigert C; Klerdal K; Hammar N; Hallqvist J; Gustavsson P
Article: JOURNAL OF INTERNAL MEDICINE. 2004;256(5):437-445
Hormone therapy and mortality during a 14-year follow-up of 14 324 Norwegian women
Graff-Iversen S; Hammar N; Thelle DS; Tonstad S
Article: JOURNAL OF INTERNAL MEDICINE. 2004;255(6):645-652
Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women
Agardh EE; Carlsson S; Ahlbom A; Efendic S; Grill V; Hammar N; Hilding A; Östenson CG
Article: RADIATION AND ENVIRONMENTAL BIOPHYSICS. 2004;42(4):247-256
Cosmic radiation and cancer mortality among airline pilots:: results from a European cohort study (ESCAPE)
Langner I; Blettner M; Gundestrup M; Storm H; Aspholm R; Auvinen A; Pukkala E; Hammer GP; Zeeb H; Hrafnkelsson J; Rafnsson V; Tulinius H; De Angelis G; Verdecchia A; Haldorsen T; Tveten U; Eliasch H; Hammar N; Linnersjö A
Journal article: VASCULAR. 2003;11(6):497-505
Classification of Left Main Coronary Obstruction—Feasibility of Surgical Angioplasty and Survival after Coronary Artery Bypass Surgery
Jönsson A; Ivert T; Svane B; Liska J; Jakobsson K; Hammar N
Article: VASCULAR. 2003;11(6):497-505
Classification of left main coronary obstruction-feasibility of surgical angioplasty and survival after coronary artery bypass surgery
Jönsson A; Ivert T; Svane B; Liska J; Jakobsson K; Hammar N
Article: OCCUPATIONAL AND ENVIRONMENTAL MEDICINE. 2003;60(11):810-814
Cancer incidence in airline cabin crew:: experience from Sweden
Linnersjö A; Hammar N; Dammström BG; Johansson M; Eliasch H
Article: INTERNATIONAL JOURNAL OF CANCER. 2003;106(6):946-952
Mortality from cancer and other causes among male airline cockpit crew in Europe
Blettner M; Zeeb H; Auvinen A; Ballard TJ; Caldora M; Eliasch H; Gundestrup M; Haldorsen T; Hammar N; Hammer GP; Irvine D; Langner I; Paridou A; Pukkala E; Rafnsson V; Storm H; Tulinius H; Tveten U; Tzonou A
Article: ADDICTION. 2003;98(10):1453-1462
Abstention, alcohol use and risk of myocardial infarction in men and women taking account of social support and working conditions:: the SHEEP case-control study
Romelsjö A; Branting M; Hallqvist J; Alfredsson L; Hammar N; Leifman A; Ahlbom A
Article: DIABETES CARE. 2003;26(10):2785-2790
Alcohol consumption and the incidence of type 2 diabetes - A 20-year follow-up of the Finnish Twin Cohort Study
Carlsson S; Hammar N; Grill V; Kaprio J
Article: CLINICAL SCIENCE. 2003;105(3):303-313
Higher prevalence of Chlamydia pneumoniae seropositivity in Finnish twins compared with co-twins living in Sweden:: relationships with markers of subclinical atherosclerosis
Jartti L; Raitakari OT; Järvisalo MJ; Hammar N; Kaprio J; Koskenvuo M; Marniemi J; Saikku P; Rönnemaa T
Article: EUROPEAN JOURNAL OF PUBLIC HEALTH. 2003;13(3 Suppl):55-60
Coronary and cerebrovascular population-based registers in Europe: are morbidity indicators comparable? Results from the EUROCISS Project
Steinbach K; Kornitzer M; de Smet P; Madsen M; Lang T; Paterniti S; Salomaa V; Doring A; Loewel H; Bloemberg B; Graff-Iversen S; Rocha E; Miguel JP; Sans S; Hammar N; Pedoe HT; Rayner M; Petersen S; Giampaoli S; Palmieri L; Seccareccia F; Ferrario M; Vanuzzo D
Article: EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2003;57(9):1035-1044
Comparison of nutrient intake data calculated on the basis of two different databases. Results and experiences from a Swedish-Finnish study
Hakala P; Knuts LR; Vuorinen A; Hammar N; Becker W
Article: AMERICAN HEART JOURNAL. 2003;146(3):555-560
Obesity and the risk of early and late mortality after coronary artery bypass graft surgery
Kim J; Hammar N; Jakobsson K; Luepker RV; McGovern PG; Ivert T
Article: AVIATION SPACE AND ENVIRONMENTAL MEDICINE. 2003;74(7):699-706
Cancer incidence among 10,211 airline pilots:: A Nordic study
Pukkala E; Aspholm R; Auvinen A; Eliasch H; Gundestrup M; Haldorsen T; Hammar N; Hrafnkelsson J; Kyyrönen P; Linnersjö A; Rafnsson V; Storm H; Tveten U
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2003;158(1):35-46
Mortality from cancer and other causes among airline cabin attendants in Europe:: A collaborative cohort study in eight countries
Zeeb H; Blettner M; Langner I; Hammer GP; Ballard TJ; Santaquilani M; Gundestrup M; Storm H; Haldorsen T; Tveten U; Hammar N; Linnersjö A; Velonakis E; Tzonou A; Auvinen A; Pukkala E; Rafnsson V; Hrafnkelsson J
Article: LAKARTIDNINGEN. 2003;100(26-27):2297-2299
[A certain increase of skin cancer among pilots].
Hammar N; Eliasch H; Linnersjö A; Dammström B-G; Johansson M; Pukkala E
Article: JOURNAL OF INTERNAL MEDICINE. 2003;253(6):653-659
Association of boiled and filtered coffee with incidence of first nonfatal myocardial infarction: the SHEEP and the VHEEP study
Hammar N; Andersson T; Alfredsson L; Reuterwall C; Nilsson T; Hallqvist J; Knutsson A; Ahlbom A
Article: ATHEROSCLEROSIS. 2003;167(2):319-326
Enhanced endothelium-dependent vasodilation in subjects with proline7 substitution in the signal peptide of neuropeptide Y
Järvisalo MJ; Jartti L; Karvonen MK; Pesonen U; Koulu M; Marniemi J; Hammar N; Kaprio J; Paakkunainen U; Simell O; Raitakari OT; Rönnemaa T
Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY (EJE). 2003;18(6):493-501
Assessment of alcohol consumption by mailed questionnaire in epidemiological studies:: Evaluation of misclassification using a dietary history interview and biochemical markers
Carlsson S; Hammar N; Hakala P; Kaprio J; Marniemi J; Rönnemaa T
Article: THE BMJ. 2002;325(7364):567-569
Incidence of cancer among Nordic airline pilots over five decades:: occupational cohort study
Pukkala E; Aspholm R; Auvinen A; Eliasch H; Gundestrup M; Haldorsen T; Hammar N; Hrafnkelsson J; Kyyrönen P; Linnersjö A; Raffnsson V; Storm H; Tveten U
Journal article: INTERNATIONAL CONGRESS SERIES. 2002;1241:165-171
Job strain, effort–reward imbalance, and coronary risk factors—complementary job stress models in risk estimation?
Peter R; Alfredsson L; Hammar N; Siegrist J; Theorell T; Westerholm P
Article: SCANDINAVIAN JOURNAL OF WORK, ENVIRONMENT & HEALTH. 2002;28(4):238-248
Job strain and major risk factors for coronary heart disease among employed males and females in a Swedish study on work, lipids and fibrinogen
Alfredsson L; Hammar N; Fransson E; de Faire U; Hallqvist J; Knutsson A; Nilsson T; Theorell T; Westerholm P
Article: ANNALS OF MEDICINE. 2002;34(3):162-170
Increased carotid intima-media thickness in men born in east Finland:: a twin study of the effects of birthplace and migration to Sweden on subclinical atherosclerosis
Jartti L; Raitakari OT; Kaprio J; Järvisalo MJ; Toikka JO; Marniemi J; Hammar N; Luotolahti M; Koskenvuo M; Rönnemaa T
Article: JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH. 2002;56(5):362-366
Migration and mortality:: a 20 year follow up of Finnish twin pairs with migrant co-twins in Sweden
Hammar N; Kaprio J; Hagström U; Alfredsson L; Koskenvuo M; Hammar T
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2002;22(5):832-837
Population-based twin study of the effects of migration from Finland to Sweden on endothelial function and intima-media thickness
Jartti L; Rönnemaa T; Kaprio J; Järvisalo MJ; Toikka JO; Marniemi J; Hammar N; Alfredsson L; Saraste M; Hartiala J; Koskenvuo M; Raitakari OT
Article: AVIATION SPACE AND ENVIRONMENTAL MEDICINE. 2002;73(1):2-7
Cancer incidence in airline and military pilots in Sweden -: 1961-1996
Hammar N; Linnersjö A; Alfredsson L; Dammström BG; Johansson M; Eliasch H
Article: SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES. 2001;18(3):284-288
ECG-abnormalities in Japanese and Swedish patients with sarcoidosis.: A comparison
Larsen F; Pehrsson SK; Hammar N; Sköld CM; Izumi T; Nagai S; Shigematsu M; Eklund A
Article: SCHIZOPHRENIA RESEARCH. 2001;47(2-3):247-254
Time trends in first admissions for schizophrenia and paranoid psychosis in Stockholm County, Sweden
Ösby U; Hammar N; Brandt L; Wicks S; Thinsz Z; Ekbom A; Sparén P
Article: EUROPEAN HEART JOURNAL. 2001;22(4):314-322
Sex differences in survival after myocardial infarction in Sweden -: Data from the Swedish National Acute Myocardial Infarction Register
Rosengren A; Spetz CL; Köster M; Hammar N; Alfredsson L; Rosen M
Article: JOURNAL OF INTERNAL MEDICINE. 2001;249(2):137-144
Geographical differences in the incidence of acute myocardial infarction in Sweden. Analyses of possible causes using two parallel case-control studies
Hammar N; Andersson T; Reuterwall C; Nilsson T; Knutsson A; Hallqvist J; Ahlbom A
Article: AMERICAN HEART JOURNAL. 2001;141(1):9-14
Early and late mortality after surgery for unstable angina in relation to Braunwald class
Bjessmo S; Ivert T; Flink H; Hammar N
Article: DIABETIC MEDICINE. 2000;17(11):776-781
Alcohol consumption, Type 2 diabetes mellitus and impaired glucose tolerance in middle-aged Swedish men
Carlsson S; Hammar N; Efendic S; Persson PG; Östenson CG; Grill V
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2000;76(1):17-21
Recent time trends in acute myocardial infarction in Stockholm, Sweden
Linnersjö A; Hammar N; Gustavsson A; Reuterwall C
Article: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2000;18(4):388-392
Reduced risk of coronary artery bypass surgery for unstable angina during a 6-year period
Bjessmo S; Hammar N; Sandberg E; Ivert T
Article: JOURNAL OF INTERNAL MEDICINE. 2000;248(2):159-164
Attack rate, mortality and case fatality for acute myocardial infarction in Sweden during 1987-95.: Results from the National AMI Register in Sweden
Rosén M; Alfredsson L; Hammar N; Kahan T; Spetz CL; Ysberg AS
Journal article: ATHEROSCLEROSIS. 2000;151(1):212
Proline7 substitution in the prepro neuropeptide Y (NPY) is associated with enhanced brachial artery flow-mediated dilatation in middle-aged men
Jartti L; Karvonen M; Järvisalo M; Toikka J; Raitakari O; Pesonen U; Koulu M; Marniemi J; Hammar N; Kaprio J; Rönnemaa T
Article: LAKARTIDNINGEN. 2000;97(9):972-974
[Obesity doesn't increase the risks of coronary surgery. Results from a study of 7,248 patients who underwent the surgery].
Ivert T; Sandberg E; Hammar N
Article: UROLOGY. 2000;55(2):236-240
Incidence of acute myocardial infarction and cause-specific mortality after transurethral treatments of prostatic hypertrophy
Hahn RG; Farahmand BY; Kallin A; Hammar N; Persson PG
Article: OCCUPATIONAL AND ENVIRONMENTAL MEDICINE. 1998;55(9):642-644
Myocardial infarction in male and female dominated occupations
Ostlin P; Alfredsson L; Hammar N; Reuterwall C
Article: JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH. 1998;52(9):540-547
High effort, low reward, and cardiovascular risk factors in employed Swedish men and women: baseline results from the WOLF Study
Peter R; Alfredsson L; Hammar N; Siegrist J; Theorell T; Westerholm P
Article: OCCUPATIONAL AND ENVIRONMENTAL MEDICINE. 1998;55(8):548-553
Job strain, social support at work, and incidence of myocardial infarction
Hammar N; Alfredsson L; Johnson JV
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 1998;40(2):359-363
Myocardial infarction among women with early-stage breast cancer treated with conservative surgery and breast irradiation
Rutqvist LE; Liedberg A; Hammar N; Dalberg K
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1997;29(3):659-664
Comparison of early and late mortality in men and women after isolated coronary artery bypass graft surgery in Stockholm, Sweden, 1980 to 1989
Hammar N; Sandberg E; Larsen FF; Ivert T
Article: LAKARTIDNINGEN. 1997;94(7):529-533
[Is gender minority at workplaces a risk of myocardial infarction?].
Ostlin P; Alfredsson L; Hammar N; Reuterwall C
Article: JOURNAL OF INTERNAL MEDICINE. 1997;241(2):125-131
Alcohol consumption, drinking pattern and acute myocardial infarction. A case referent study based on the Swedish Twin Register
Hammar N; Romelsjo A; Alfredsson L
Article: CANCER CAUSES AND CONTROL. 1996;7(3):377-381
Cancer incidence among male railway engine-drivers and conductors in Sweden, 1976-90
Alfredsson L; Hammar N; Karlehagen S
Article: OCCUPATIONAL AND ENVIRONMENTAL MEDICINE. 1996;53(4):235-240
Myocardial infarction among male bus, taxi, and lorry drivers in middle Sweden
Gustavsson P; Alfredsson L; Brunnberg H; Hammar N; Jakobsson R; Reuterwall C; Ostlin P
Article: LAKARTIDNINGEN. 1995;92(17):1779-1781
[Greater chance to survive a myocardial infarction. Changed therapeutic methods may play an important role].
Hammar N; Larsen F; Alfredsson L; Sandberg E
Article: NUTRITION, METABOLISM AND CARDIOVASCULAR DISEASES. 1995;5(2):99-104
INCREASING DIFFERENCES IN MYOCARDIAL-INFARCTION INCIDENCE BETWEEN SOCIOECONOMIC GROUPS IN STOCKHOLM
ALFREDSSON L; HAMMAR N; GILLSTROM P
Journal article: JOURNAL OF CLINICAL EPIDEMIOLOGY. 1994;47(6):685-693
ARE GEOGRAPHICAL DIFFERENCES AND TIME TRENDS IN MYOCARDIAL-INFARCTION INCIDENCE IN SWEDEN REAL - VALIDITY OF HOSPITAL DISCHARGE DIAGNOSES
HAMMAR N; LARSEN FF; DEFAIRE U
Journal article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 1994;23(2):277-284
JOB CHARACTERISTICS AND THE INCIDENCE OF MYOCARDIAL-INFARCTION
HAMMAR N; ALFREDSSON L; THEORELL T
Journal article: LAKARTIDNINGEN. 1993;90(26-27):2447-2448
[Myocardial infarction among younger women. Current data shows decreased occurrence].
Hammar N; Alfredsson L
Journal article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 1993;22(1):57-61
INCIDENCE OF MYOCARDIAL-INFARCTION AND MORTALITY FROM SPECIFIC CAUSES AMONG BUS DRIVERS IN SWEDEN
ALFREDSSON L; HAMMAR N; HOGSTEDT C
Journal article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 1992;21(6):1090-1096
TIME TRENDS IN SURVIVAL FROM MYOCARDIAL-INFARCTION IN STOCKHOLM COUNTY 1976-1984
HAMMAR N; LARSEN FF; SANDBERG E; ALFREDSSON L; THEORELL T
Journal article: EPIDEMIOLOGY. 1992;3(4):348-355
GEOGRAPHICAL DIFFERENCES IN MYOCARDIAL-INFARCTION INCIDENCE IN 8 SWEDISH COUNTIES, 1976-1981
HAMMAR N; AHLBOM A; THEORELL T
Journal article: SCANDINAVIAN JOURNAL OF WORK, ENVIRONMENT & HEALTH. 1992;18(3):178-185
DIFFERENCES IN THE INCIDENCE OF MYOCARDIAL-INFARCTION AMONG OCCUPATIONAL GROUPS
HAMMAR N; ALFREDSSON L; SMEDBERG M; AHLBOM A
Journal article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 1991;20(3):621-627
RETROSPECTIVE VERSUS ORIGINAL INFORMATION ON DIET AMONG CASES OF COLORECTAL-CANCER AND CONTROLS
HAMMAR N; NORELL SE
Journal article: LAKARTIDNINGEN. 1991;88(19):1770-1776
[Epidemiologic surveillance of myocardial infarction shows fewer cases but large regional differences].
Hammar N; Sandberg E; Ahlbom A; Alfredsson L; Leimanis A
Journal article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 1991;20(1):114-120
IDENTIFICATION OF CASES OF MYOCARDIAL-INFARCTION - HOSPITAL DISCHARGE DATA AND MORTALITY DATA COMPARED TO MYOCARDIAL-INFARCTION COMMUNITY REGISTERS
HAMMAR N; NERBRAND C; AHLMARK G; TIBBLIN G; TSIPOGIANNI A; JOHANSSON S; WILHELMSEN L; JACOBSSON S; HANSEN O
Journal article: LAKARTIDNINGEN. 1990;87(7):474-476
[Risk of myocardial infarction is increased among transportation and industry workers].
Alfredsson L; Hammar N; Ahlbom A; Hogstedt C; Plato N; Smedberg M; Theorell T
Journal article: THE BMJ. 1987;294(6572):609-610
Recent trends in mortality from and incidence of myocardial infarction in Stockholm.
Hammar N; Ahlbom A
Journal article: ENVIRONMENTAL HEALTH PERSPECTIVES. 1986;70:239-245
Respiratory symptoms and annoyance in the vicinity of coal-fired plants.
Pershagen G; Hammar N; Vartiainen E
Journal article: JOURNAL OF SOUND AND VIBRATION. 1983;87(2):315-319
Annoyance reactions due to railway noise
Sörensen S; Hammar N
Journal article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 1982;11(4):387-390
A CROSS-NATIONAL EPIDEMIOLOGICAL RESOURCE - THE SWEDISH AND FINNISH COHORT STUDIES OF LIKE-SEXED TWINS
CEDERLOF R; RANTASALO I; FLODERUSMYRHED B; HAMMAR N; KAPRIO J; KOSKENVUO M; LANGINVAINIO H; SARNA S
Journal article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 1982;11(4):378-386
CIGARETTE-SMOKING AND ALCOHOL-USE IN FINLAND AND SWEDEN - A CROSS-NATIONAL TWIN STUDY
KAPRIO J; HAMMAR N; KOSKENVUO M; FLODERUSMYRHED B; LANGINVAINIO H; SARNA S
Visa fler

Alla övriga publikationer

Corrigendum: GEROSCIENCE. 2024;46(2):2793-2794
Correction to: Blood biomarker profiles and exceptional longevity: comparison of centenarians and non-centenarians in a 35-year follow-up of the Swedish AMORIS cohort
Murata S; Ebeling M; Meyer AC; Schmidt-Mende K; Hammar N; Modig K
Book chapter: HANDBOOK OF PREVENTION AND ALZHEIMER’S DISEASE: ADVANCES IN ALZHEIMER'S DISEASE. 2024;p.
Glucose-Lowering Medications and Post-Dementia Survival in Patients with Diabetes and Dementia
Secnik J; Xu H; Schwertner E; Hammar N; Alvarsson M; Winblad B; Eriksdotter M; Garcia-Ptacek S; Religa D
Editorial comment: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2023;57(6):728
Editorial: moving from the clinic towards population hepatology-authors' reply
Hagstrom H; Hammar N
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022;31:626
The social patterning of COVID-19 vaccine uptake in older adults: A register-based study in Sweden within the SCIFIPEARL project
Nyberg F; Spetz M; Lundberg L; Nwaru C; Li H; Santosa A; Leach S; Gisslen M; Hammar N; Rosvall M
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S24
Prediction of ten-year risk of severe liver disease in the general population using commonly available biomarkers
Hagstrom H; Yan J; Talback M; Andreasson A; Walldius G; Bottai M; Hammar N
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S119-S120
Biomarkers for prediction of alcohol-related liver cirrhosis in the Swedish general population
Jakobsson G; Talback M; Walldius G; Hammar N; Hagstrom H
Conference publication: BLOOD. 2021;138:4382
Association of Inflammatory Markers and Blood Cell Counts and the Risk of Leukemia in the Swedish Amoris Cohort
Sami MA; Feychting M; Hammar N; Walldius G; Van Hemelrijck M; Kordasti S; Santaolalla A
Preprint: MEDRXIV. 2021
Adverse events of special interest for COVID-19 vaccines - background incidences vary by sex, age and time period and are affected by the pandemic
Nyberg F; Lindh M; Vanfleteren LEGW; Hammar N; Wettermark B; Sundström J; Santosa A; Kirui BK; Gisslén M
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2021;30:347-348
Swedish Covid-19 investigation for future insights - a population epidemiology approach using register linkage (SCIFI- PEARL)
Nyberg F; Franzen S; Santosa A; Vanfleteren LEGW; Hammar N; Sundstrom J; Lindh M; Bjorck S; Gisslen M; Wettermark B
Conference publication: DIABETOLOGIA. 2021;64(SUPPL 1):42
Alterations in biomarkers of carbohydrate and lipid metabolism up to 20 years before the diagnosis of type 1 diabetes: findings from the AMORIS cohort
Herzog K; Grill VER; Hammar N; Malmstrom H; Talback M; Walldius G; Carlsson S
Preprint: RESEARCH SQUARE. 2020
Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study
santaolalla A; Sollie S; Rislan A; Josephs DH; Hammar N; Walldius G; Jungner I; Garmo H; Karagiannis SN; Hemelrijck MV
Preprint: RESEARCH SQUARE. 2020
Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study
santaolalla A; Sollie S; Rislan A; Josephs DH; Hammar N; Walldius G; Jungner I; Karagiannis SN; Hemelrijck MV
Review: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2020;29(3):527-538
Association of Serum Immunoglobulin Levels with Solid Cancer: A Systematic Review and Meta-analysis
Peppas IS; George G; Sollie S; Josephs DH; Hammar N; Walldius G; Karagiannis SN; Van Hemelrijck M
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2020;27:1019-1020
Changes in antidiabetic drug prescription among patients with dementia and diabetes mellitus: Longitudinal analyses using Swedish national registers over 14-years.
Secnik J; Xu H; Schwertner E; Hammar N; Alvarsson M; Winblad B; Eriksdotter M; Garcia-Ptacek S; Religa D
Conference publication: DIABETOLOGIA. 2020;63(SUPPL 1):S141-S142
Impact of micro- and macrovascular complications of type 2 diabetes on quality of life: insights from the DISCOVER study
Arnold SV; Khunti K; Tang F; Gomes MB; Ji L; Nicolucci A; Shestakova MV; Watada H; Cooper A; Hammar N; Fenici P; Medina J; Kosiborod M
Conference publication: DIABETOLOGIA. 2020;63(SUPPL 1):S148-S149
Impact of early or late intensification of glucose-lowering therapy in patients with type 2 diabetes: the global DISCOVER study
Ramirez L; Ji L; Bonnet F; Chen H; Cooper A; Hammar N; Leigh P; Saraiva GL; Medina J; Nicolucci A; Rathmann W; Shestakova MV; Surmont F; Tang F; Watada H
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S70-S71
Repeated measures of FIB-4 improve prediction of severe liver disease: population-based cohort study of 40,729 individuals
Hagstrom H; Talback M; Andreasson A; Walldius G; Hammar N
Conference publication: DIABETOLOGIE UND STOFFWECHSEL. 2019;14:s66-s67
Ein geringeres Risiko für CV-Ereignisse und Tod ist mit dem Therapiebeginn mit SGLT-2 vs. DPP-4 Inhibitoren assoziiert – Analyse der CVD-REAL-2-Studie
Kohsaka S; Lam C; Kim D; Karasik A; Tangri N; Goh S; Thuresson M; Chen H; Surmont F; Hammar N; Fenici P; Kosiborod M; Rist R
Conference publication: EUROPEAN HEART JOURNAL. 2019;40:58
Glucose is associated with future atrial fibrillation and heart failure already at prediabetes levels, a 19 year follow up of 243,665 subjects
Lind V; Hammar N; Lundman P; Friberg L; Tallback M; Walldius G; Norhammar A
Conference publication: JOURNAL OF HEPATOLOGY. 2019;70(1):E769
Prediction of incident severe liver disease in the general population using non-invasive scoring systems
Hagstrom H; Talback M; Andreasson A; Carlsson A; Walldius G; Hammar N
Letter: DIABETES CARE. 2018;41(6):e106-e108
Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10
Thuresson M; Cavender MA; Fu AZ; Wilding JP; Khunti K; Holl RW; Norhammar A; Birkeland KI; Jorgensen ME; Wittbrodt E; Hammar N; Fenici P; Kosiborod M
Conference publication: DIABETOLOGIE UND STOFFWECHSEL. 2018;13:s68
Hospitalisierung aufgrund von Herzinsuffizienz und Mortalität bei Neueinstellung auf SGLT-2 Inhibitoren bei Patienten mit und ohne kardiovaskulärer Erkrankung: die CVD-REAL-Studie
Cavender M; Norhammar A; Birkeland K; Jörgensen M; Wilding J; Khunti K; Fu A; Bodegard J; Blak B; Wittbrodt E; Thuresson M; Fenici P; Hammar N; Kosiborod M; Costa MR
Letter: CIRCULATION. 2018;137(9):989-991
Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"
Kosiborod M; Cavender MA; Fu AZ; Wilding JP; Khunti K; Holl RW; Norhammar A; Birkeland KI; Jorgensen ME; Thuresson M; Arya N; Bodegard J; Hammar N; Fenici P
Review: DIABETES, OBESITY AND METABOLISM. 2018;20(2):427-437
Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review
Khunti K; Gomes MB; Pocock S; Shestakova MV; Pintat S; Fenici P; Hammar N; Medina J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27:228-229
The discover study: Diversity of sites, physicians, and patients
Rathmann W; Medina J; Kosiborod M; Nicolucci A; Cid-Ruzafa J; Fenici P; Hammar N; Surmont F; Khunti K
Conference publication: EUROPEAN HEART JOURNAL. 2018;39:879
Favourable long-term effects of a cardiovascular prevention program in primary health care in Sweden in men, and women on first cardiovascular events, cardiovascular mortality, and all-cause mortality
Journath G; Hammar N; Hammar N; Vikstrom M; Linnersjo A; Linnersjo A; Walldius G; Krakau I; Lindgren P; De Faire U; Hellenius ML
Conference publication: DIABETOLOGIE UND STOFFWECHSEL. 2017;12(03):222-228
Gesamtereignisraten für die Hospitalisierung bei Herzinsuffizienz (HHI) bei Neueinstellung auf SGLT-2-Hemmer im Vergleich zu anderen Antidiabetika – Daten aus dem klinischen Alltag aus Deutschland, Schweden und Norwegen mit mehr als 45.000 Typ 2 Diabetes Patienten (CVD-Real)
Scheerer M; Kosiborod M; Norhammar A; Birkeland K; Hammar N; Bodegard J; Thuresson M; Holl R; Fenici P
Conference publication: DIABETOLOGIE UND STOFFWECHSEL. 2017;12(03):222-228
Positive Einflüsse auf die Hospitalisierung für Herzinsuffizienz (HHI) und Gesamtmortalität bei Neueinstellung auf SGLT-2 Inhibitoren im Vergleich zu anderen Antidiabetika: Gesamtergebnisse von mehr als 300.000 Patienten aus dem klinischen Alltag – CVD-REAL Studie
Scheerer M; Kosiborod M; Cavender M; Fu A; Wilding J; Norhammar A; Birkeland K; Jorgensen M; Thuresson M; Arya N; Bodegard J; Hammar N; Holl R; Fenici P
Conference publication: DIABETOLOGIA. 2017;60:S518-S519
Global prevalence of type 2 diabetes complications in 14,391 patients initiating second-line therapy: the DISCOVER study
Shestakova MV; Khunti K; Arya N; Cid-Ruzafa J; Fenici P; Gomes MB; Hammar N; Nicolucci A; Pocock S; Rathmann W; Watada H; Shimomura I; Tang F; Kosiborod M
Conference publication: DIABETOLOGIA. 2017;60:S140
Glycaemic, lipid and blood pressure control according to guidelines in patients initiating second-line glucose-lowering therapy: results from the global DISCOVER study
Gomes MB; Charbonnel B; Cid-Ruzafa J; Fenici P; Hammar N; Khunti K; Kosiborod M; Nicolucci A; Pocock S; Shestakova MV; Watada H; Shimomura I; Tang F; Ji L
Conference publication: DIABETOLOGIA. 2017;60:S140-S141
Glycaemic control in 14,005 patients with type 2 diabetes initiating second-line therapy in 36 countries: the DISCOVER study
Ji L; Nicolucci A; Arya N; Cid-Ruzafa J; Fenici P; Gomes MB; Hammar N; Kosiborod M; Pocock S; Shestakova MV; Watada H; Shimomura I; Tang F; Khunti K
Conference publication: DIABETOLOGIA. 2017;60:S41
Hospitalisation for heart failure and death in new users of SGLT-2 inhibitors in patients with and without cardiovascular disease: the CVDREAL study
Cavender MA; Norhammar A; Birkeland KI; Jorgensen ME; Wilding P; Khunti K; Fu AZ; Bodegard J; Blak B; Wittbrodt ET; Thuresson M; Fenici P; Hammar N; Kosiborod M
Conference publication: DIABETOLOGIA. 2017;60:S41-S42
Total events of hospitalisation for heart failure in new users of SGLT-2 inhibitors: real world data from 5 countries and more than 298,000 patients: the CVD-REAL study
Kosiborod M; Cavender MA; Fu AZ; Norhammar A; Birkeland KI; Jorgensen M; Holl RW; Hammar N; Wittbrodt ET; Bodegard J; Scheerer M; Thuresson M; Fenici P
Conference publication: DIABETOLOGIA. 2017;60:S301-S302
Treatment patterns and associated factors in 13,379 patients with type 2 diabetes initiating a second-line therapy: the DISCOVER study
Nicolucci A; Arya N; Charbonnel B; Cid-Ruzafa J; Fenici P; Gomes MB; Hammar N; Khunti K; Kosiborod M; Shestakova MV; Watada H; Shimomura I; Tang F; Pocock S
Letter: DIABETES CARE. 2016;39(7):e99-e101
Evaluating the Quality of Comprehensive Cardiometabolic Care for Patients With Type 2 Diabetes in the U.S.: The Diabetes Collaborative Registry.
Arnold SV; Inzucchi SE; McGuire DK; Mehta SN; Goyal A; Sperling LS; Maddox TM; Einhorn D; Wong ND; Ratner RE; Hammar N; Fenici P; Sheehan JJ; Wong JL; Kosiborod M
Conference publication: CANCER RESEARCH. 2016;76:p5-07-06-p5-07-06
A competing risks analysis of the association between prediagnostic serum glucose and lipids and breast cancer survival
Wulaningsih W; Vandaninia M; Rowley M; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Coolen A; Van Hemelrijck M
Conference publication: DIABETOLOGIA. 2016;59:S52-S53
Low fructosamine levels and mortality: a 25-year follow-up of 215,011 Swedish non-diabetic subjects
Malmstrom H; Wandell P; Holzmann MJ; Arnlov J; Jungner I; Walldius G; Hammar N; Carlsson AC
Preprint: ARXIV. 2015
Practical survival analysis tools for heterogeneous cohorts and informative censoring
Rowley M; Garmo H; Van Hemelrijck M; Wulaningsih W; Grundmark B; Zethelius B; Hammar N; Walldius G; Inoue M; Holmberg L; Coolen ACC
Conference publication: EUROPEAN JOURNAL OF CANCER. 2015;51:S152
High serum glucose and triglycerides are associated with increased risk of severe prostate cancer among Swedish men
Arthur R; Moller H; Garmo H; Hammar N; Walldius G; Jungner I; Om HM; Lambe M; Holmberg L; Van Hemelrijck M
Conference publication: EUROPEAN JOURNAL OF CANCER. 2015;51:S148
Serum lactate dehydrogenase and survival following cancer diagnosis
Wulaningsih W; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Ng T; Van Hemelrijck M
Conference publication: ATHEROSCLEROSIS. 2015;241(1):E135
ASSOCIATION BETWEEN SERUM CALCIUM CONCENTRATION AND RISK OF INCIDENT AND FATAL MYOCARDIAL INFARCTION AND STROKE IN THE AMORIS COHORT
Rohrmann S; Garmo H; Om HM; Hammar N; Jungner I; Walldius G; Van Hemelrijck M
Conference publication: EUROPEAN HEART JOURNAL. 2015;36:1201
Long-term effects of a cardiovascular prevention program in primary health care in Sweden
Journath G; Hammar N; Linnersjo A; Vikstrom M; Walldius G; Krakau I; Lindgren P; De Faire U; Hellenius M-L
Conference publication: ANNALS OF ONCOLOGY. 2015;26:12
Atopy and cancer risk: Insights from a prospective study on serum specific and total immunoglobulin E
Wulaningsih W; Garmo H; Holmberg L; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; van Hemelrijck M
Conference publication: DIABETOLOGIA. 2015;58:S135
Fructosamine is a risk factor for myocardial infarction and all-cause mortality: longitudinal experience from the AMORIS cohort
Malmstrom H; Walldius G; Grill V; Jungner I; Hammar N
Conference publication: DIABETOLOGIA. 2015;58:S64-S65
Treatment characteristics and outcomes associated with sulphonylurea versus metformin therapy in incident type 2 diabetes mellitus patients: results of the German CREST study
Berg B; Wilke T; Groth A; Mueller S; Stephens S; Hammar N; Fuchs A; Tsai K; Maywald U
Conference publication: EUROPEAN HEART JOURNAL. 2014;35:1068
Trends in acute myocardial infarction incidence and mortality a long term follow-up of a primary prevention program in Sweden
Journath G; Hammar N; Elofsson S; Linnersjo A; Krakau I; Walldius G; De Faire U; Hellenius M-L
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(5):36
Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study
Van Hemelrijck M; Hermans R; Michaelsson K; Garmo H; Hammar N; Jungner I; Walldius G; Lambe M; Holmberg L
Conference publication: EUROPEAN HEART JOURNAL. 2012;33:442
Utilization of prophylactic drug therapy after acute myocardial infarction in Abu Dhabi
Harrison O; Al Jaberi KA; Hassan ES; Kedvik T; Gjurovic AM; Franzen S; Wettermark B; Leimanis A; Hammar N; Engstrom G
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(7):342
Lipid profiles and the risk of kidney cancer in the Swedish AMORIS study
Van Hemelrijck M; Garmo H; Hammar N; Walldius G; Lambe M; Jungner I; Holmberg L
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2011;20:S287-S288
Risk Factors Associated with the Incidence of Urinary Tract Infections among Patients with Type 2 Diabetes in a Community Practice Setting in the UK
Gomez-Caminero A; Hirji I; Andersson S; Hammar N
Conference publication: EUROPEAN UROLOGY OPEN SCIENCE. 2011;10(2):207
RISK OF PROSTATE CANCER IS NOT ASSOCIATED WITH LEVELS OF C-REACTIVE PROTEIN AND OTHER COMMONLY USED MARKERS OF INFLAMMATION
Van Hemelrijck MJJ; Jugner I; Walldius G; Garmo H; Binda E; Hayday A; Lambe M; Holmberg L; Hammar N
Conference publication: EUROPEAN UROLOGY OPEN SCIENCE. 2010;9(2):244
PROSTATE CANCER RISK IN THE SWEDISH AMORIS STUDY: THE INTERPLAY BETWEEN TRIGLYCERIDES, TOTAL CHOLESTEROL AND GLUCOSE
Van Hemelrijck MJJ; Holmberg L; Garmo H; Walldius G; Jungner I; Hammar N; Lamber M
Conference publication: EUROPEAN JOURNAL OF PUBLIC HEALTH. 2010;20:229
Disability pension after coronary revascularization. A 15-year follow-up in Sweden
Voss M; Vaez M; Alexanderson K; Ivert T; Pehrsson K; Hammar N
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2010;19:S23
Cardiovascular Drug Use in Patients Hospitalized with a First-Time Myocardial Infarction in Sweden
Leimanis A; Fored M; Hammar N; Schioler H; Wettermark B
Conference publication: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2010;171:S22
EVIDENCE OF INCREASED RISK OF ENDOMETRIAL AND POSTMENOPAUSAL BREAST CANCER IN WOMEN WITH HYPERGLYCAEMIA BELOW THE DIAGNOSTIC THRESHOLD OF DIABETES
Lambe M; Wigertz A; Garmo H; Walldius G; Jungner I; Hammar N
Conference publication: CIRCULATION. 2009;120(18):S654
Digoxin in Atrial Fibrillation - From the Stockholm Cohort-study of Atrial Fibrillation (SCAF)
Friberg L; Hammar N; Rosenqvist M
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2009;18:S60
Increasing Prevalence and Incidence of Drug Use in Sweden-Data from the National Prescribed Drug Register
Leimanis A; Ericsson O; Fored M; Hammar N; Wettermark B
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2009;18:S41-S42
Incidence of Urinary Tract Infection in Subjects with Type 2 Diabetes. Experience from Adverse Event Reporting in Diabetes Clinical Trials
Hammar N; Farahmand B; Andersson S; Joelson S; Gran M
Corrigendum: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2008;17(5):533
The new Swedish Prescribed Drug Register-Opportunities for pharmacoepidemiological research and experience from the first six months (vol 16, 726, 2007)
Wettermark B; Hammar N; Fored CM; Leimanis A; Olausson PO; Bergman U; Persson I; Sundstroem A; Westerholm B; Rosen M
Conference publication: DIABETOLOGIA. 2008;51:S173
The association of dyslipidaemia with cardiovascular mortality in individuals without a prior history of diabetes in the DECODE Study
Zhang L; Qiao Q; Tuomilehto J; Hammar N; Ruotolo G; Stehouwer CDA; Heine RJ; Eliasson M; Zethelius B
Conference publication: EUROPEAN HEART JOURNAL. 2008;29:468
Prognostic role of the glucometabolic status assessed in a metabolically stable phase after a first acute myocardial infarction
Janszky I; Hallqvist JH; Ljung R; Hammar N
Conference publication: EUROPEAN HEART JOURNAL. 2008;29:226
Coffee consumption and mortality following acute myocardial infarction
Janszky I; Hallqvist JH; Hammar NH; Ljung RL; Gemes GK; Ahlbom AA; Mukamal KM
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2008;17:S239-S240
Prevalence and incidence of cardiovascular drug use among women and men in Sweden
Fored M; Hammar N; Leimanis A; Wettermark B
Conference publication: EUROPEAN HEART JOURNAL. 2007;28:848-849
Chronic kidney disease, incidence of myocardial infarction and cardiovascular mortality analysed by two different formulas to estimate glomerular filtration rate
Holzmann M; Ivert T; Jungner I; Nordqvist T; Walldius G; Ostergren J; Hammar N
Conference publication: EUROPEAN HEART JOURNAL. 2007;28:689
Diabetes, impaired fasting glucose, dyslipidemia and acute myocardial infarction incidence. The AMORIS experience
Hammar N; Farahmand B; Jungner I; Johansson S; Walldius G
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2007;16:S95
Prevalence and incidence of drug use in Sweden 18 months data from the new national prescribed drug register
Fored M; Hammar N; Leimanis A; Olausson PO; Wettermark B
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2006;15:S217
A new register on prescribed pharmaceuticals in Sweden
Leimanis A; Wettermark B; Hammar N; Fored M; Olausson PO; Rosén M
Review: DIABETOLOGIA. 2005;48(6):1051-1054
Alcohol consumption and type 2 diabetes
Carlsson S; Hammar N; Grill V
Conference publication: EUROPEAN HEART JOURNAL. 2005;26:426
Creatinine clearance as a long-term predictor of myocardial infarction and death in patients undergoing coronary artery bypass surgery
Holzmann M; Ahnve S; Hammar N; Klerdal K; Nordqvist T; Pehrsson K; Ivert T
Letter: AMERICAN HEART JOURNAL. 2004;148(5):e7
Effect of obesity on risks after coronary artery bypass grafting - Reply
Kim J; Hammar N; Jakobsson K; Luepker RV; McGovern PG; Ivert T
Letter: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2004;33(3):616-617
Coffee consumption and risk of type 2 diabetes in Finnish twins
Carlsson S; Hammar N; Grill V; Kaprio J
Conference publication: EUROPEAN HEART JOURNAL. 2004;25:622
Creatinine clearance and risk of early mortality in patients undergoing coronary artery bypass grafting
Holzmann M; Ahnve S; Hammar N; Jörgensen L; Klerdal K; Pehrsson K; Ivert T
Conference publication: INTERNATIONAL JOURNAL OF PSYCHOLOGY. 2004;39(5-6):235-236
The contribution of work stress to social inequality in cardiovascular health
Peter R; Leissner N; Alfredsson L; Hammar N; Knutsson A; Siegrist J; Theorell T; Westerholm P
Published conference paper: CHRONOBIOLOGY INTERNATIONAL. 2004;21(6):1049-1053
Shift workers' mortality scrutinized
Knutsson A; Hammar N; Karlsson B
Letter: AVIATION SPACE AND ENVIRONMENTAL MEDICINE. 2003;74(2):188
Pilots & melanoma -: Response
Hammar N; Eliasch H; Linnersjö A; Dammström BG; Johansson M; Lindgren T
Book chapter: GIS FOR EMERGENCY PREPAREDNESS AND HEALTH RISK REDUCTION: NATO SCIENCE SERIES: IV:. 2002;p. 241-253
Health Characteristics of the Stockholm Population — Disease Mapping Using a Computerised System
Reuterwall C; Gustavsson A; Hammar N
Published conference paper: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2001;30:S30-S34
A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden
Hammar N; Alfredsson L; Rosén M; Spetz CL; Kahan T; Ysberg AS
Conference publication: EUROPEAN HEART JOURNAL. 2000;21:26
Sex differences in mortality after myocardial infarction in Sweden.: Data From the National AMI register
Rosengren A; Spetz CL; Köster M; Hammar N; Rosén M
Letter: NEW ENGLAND JOURNAL OF MEDICINE. 1999;341(25):1931
Coronary artery disease in men and women
Rosén M; Spetz CL; Hammar N
Letter: THE LANCET. 1998;352(9142):1786
Ischaemic heart disease in primary immunodeficiency
Hammar N; Linnersjö A; Hansson GK; Björkander J; Hammarström L
Letter: JOURNAL OF INTERNAL MEDICINE. 1998;244(4):357-358
Could time trends in myocardial infarction incidence be due to diagnostic inconsistency? A study of the validity of hospital discharge diagnoses
Bluhm G; Hammar N; Alfredsson L; Pershagen G
Conference publication: BEHAVIOR GENETICS. 1998;28(6):470
Migrant-discordant twins:: A natural experiment on effects of environmental change.
Hammar N; Kaprio J; Alfredsson L; Koskenvuo M; Rönnemaa T; Hammar T; Hagström U; Viikari L
Letter: EPIDEMIOLOGY. 1996;7(6):654-655
Time trends in the incidence of and mortality from acute myocardial infarction in Swedish women
Hammar N; Ahlbom A; Sandberg E; Alfredsson L
Visa fler

Forskningsbidrag

Real-life vaccine surveillance, immunological effect studies and infrastructure development for pandemic preparedness on a national level (RE-VISION)
Swedish Research Council
1 June 2021 - 31 May 2025
Risk, insjuknande och komplikationer av COVID-19 hos hjärt-kärl- och lungsjuka longitudinell nationell registerstudie med regelbunden datauppdatering
Swedish Heart-Lung Foundation
1 January 2021 - 31 December 2021
Demographics and other characteristics, comorbidities and risk factors for Covid-19 onset and prognosis
Swedish Research Council for Environment Agricultural Sciences and Spatial Planning
1 December 2020 - 30 November 2021
Why do we age differently? Using biomarkers and health information in midlife and onwards to increase the understanding of the human ageing process.
Swedish Research Council
1 December 2020 - 31 December 2022
Diabetes and cardiovascular disease
Swedish Heart-Lung Foundation
1 January 2019 - 31 December 2019
Epidemiologic studies of cancer development and progression using Swedish national registers
Swedish Research Council for Health Working Life and Welfare
1 December 2012 - 31 October 2015

Artiklar

Alla övriga publikationer

Forskningsbidrag

Nyheter från KI

Kalenderhändelser från KI